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The problem of decision making under uncertainty can be broken down into two
parts. First, how do we learn about the world? This involves the problem of modeling
the system and its uncertainty. Secondly, given what we currently know about
the world, how should we decide what to do, taking into account uncertainty of
future events and observations that may change our conclusions. Many systems
evolve over time and often the next state of the system is not known with certainty,
often modeled as a probability distribution over system states. Dealing with such
systems especially when we can make a decision at different points in time is difficult
due to uncertainty. Making optimal decisions requires understanding the system
including its characteristics, how it evolves and changes over time, and how taken
actions affect the system. There are multiple dimensions to this problem, and each
dimension might require its own specific method. We need a descriptive method
that can summarize the system and its evolution, a predictive model that is used to
extract information from the complicated systems and also a prescriptive model that
works as the main decision model and incorporates the effects of actions. In this
thesis I consider Partially Observable Markov Decision Process (POMDP) as the
main decision-making/prescriptive model, Hidden Markov Models (HMM) as the
descriptive model of system evolution, and a predictive model to create observations
iv
for the POMDP. In this research, I develop a framework by combining these methods
and demonstrate its use with two applications. I apply the proposed framework to
the problem of diabetes screening and also resource allocation under uncertainty
for emergency management. I demonstrate using simulation that implementing the
proposed policy will bring about significant improvements in both systems compared
to the existing policies.
Keywords: decision-making under uncertainty, predictive analytics, Markov
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The problem of decision making under uncertainty can be broken down into two parts.
First, how do we learn about the world? This involves both the problem of modeling our
uncertainty about the world, and that of drawing conclusions from evidence and our initial
information. Secondly, given what we currently know about the world, how should we
decide what to do, taking into account future events and observations that may change our
conclusions (Dimitrakakis and Ortner (2018)). In other words, understanding the system
for which we are trying to make a decision plays an important role in making an optimal
decision at any point in time. This understanding includes knowledge about the currently
most likely state of the system, and how it may evolve over time. The next step is to find a
method to make optimal decision.
Many systems evolve over time in a discrete manner where their status changes from one
state to another. Often, the state of the system is not known with certainty. Dealing with
such systems especially when we have to make a decision at some point in time is difficult
due to our uncertainty about the system. Though the short term effects of the decision made
now might be obvious to the decision maker, the long term consequences of such decisions
are hard to estimate since the system has inherent uncertainty associated with it. In other
words, the decision maker might think that the decision he is making right now is the best
since it seems to have the largest short-term reward, the long-term effects on the system are
less certain. This can be more complicated if the decisions can affect how the system changes
from one state to another. An example is called the tiger problem (Cassandra et al. (1994)),
where you are trapped in a room with two doors. Behind one of the doors is a hungry tiger
waiting to eat you while behind the other is a treasure. You have no idea behind which door
the tiger is. You can open either doors or listen to see if you can hear anything. Listening is
1
not accurate since you might hear the tiger behind the left door while it is actually behind
the right one. Making the optimal decision (how long to listen before opening a door) in
such a system demands understanding the uncertainty, and how the actions taken reduce
uncertainty.
1.1. Contributions
Making optimal decisions under uncertainty, requires understanding the system including
its characteristics, how it evolves and changes, and how the actions affect the system over
time. This demands special tools and methods to deal with, and it might also require
integration of multiple methods from different areas; methods that help us model the
underlying states of a system, and how these states evolve into each other. A descriptive
method handles modeling the system and its evolution. A prescriptive model works as the
main decision model and analyses the effects of actions and decisions on the system and in
long term. A predictive model is used to extract information from the system, providing
the decision model with information that the actual descriptive model may not be able to
provide. The major contribution of this research is the integration of these methods in a
single data-driven framework and the application to several problems. An R package named
’pomdp’ is also developed to support this research, enabling the user to easily define POMDP
models and solve them. The manual of the package can be found in the appendix.
1.2. Methodology
The main problem this research is dealing with is the difficulty of making optimal decisions
in situations that have inherent uncertainty stemming from a complex system. These systems
can often be modeled as a combination of multiple states that transition into each other with
certain probabilities. This requires methods that can model the progression of these systems
and take into account their multi-state nature. We will later see that this is the main
reason why we have chosen methods such as Partially Observable Markov Decision Process
(POMDP) as the main decision model for this research. We will clarify on the methods and
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techniques used in this research later in chapter 2 and discuss the relation between them.
In this research we use real data collected in a quantitative approach from the application
areas studied. The data collected is analyzed from various perspectives to estimate the
characteristics of the associated system it was collected from and these characteristics are
later used to simulate a duplicate of the system in order to further analyze it.
This research is mainly model-based driven by idealized model (which is usually denoted
as axiomatic research). The primary concern here is to obtain optimal solutions within the
defined model and make sure that these solutions provide insights into the structure of the
problem. Typically, axiomatic research is normative, although descriptive research, aimed
at understanding the process that has been modeled, is also present. Normative research
is primarily interested in developing policies, strategies, and actions, to improve over the
results available in the existing literature, to find an optimal solution for a newly defined
problem, or to compare various strategies for addressing a specific problem. Although in the
axiomatic domain, the discussion on methodology is largely absent, the operational research
approach of this research consists of a number of phases including (1) conceptualization,
(2) modeling, (3) model solving, and (4) implementation (Will M. Bertrand and Fransoo
(2002)).
In the conceptualization phase, we develop a conceptual model of the problem and system
being studied. We make decisions about the variables that need to be included in the model,
and the scope of the problem and model to be addressed. In the next phase, we actually build
the quantitative model, thus defining causal relationships between the variables. After this,
the model solving process takes place, in which the mathematics usually play a dominant
role. Finally the results of the model are implemented, after which a new cycle can start.
1.3. Motivations and Applications
In this research, we examine two systems each having their own characteristics and
behavior while we are trying to provide policies for the decision makers of each system,
policies that work optimally given the uncertainty in the systems. We use the proposed
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framework we talked about in the previous section of this chapter for both applications and
we demonstrate how this framework and the integration of the methods we use works for both
applications in providing optimal policies for decision makers in systems that have inherent
uncertainty. For the first system, we focus on chronic diseases such as HIV, Diabetes, and
CKD, where modeling the initial uncertainty about what stage of the disease the patient
is in and what decision should be taken with respect to the patient’s status taking into
account the future events are the major problems. For the second system, we mainly focus
on emergency management, where the uncertainty lies in which area of the city is in need
of more resources in the near future. What is common among these two systems, is first,
they are both systems that have states changing over time with uncertainty associated with
them, and second, the actions and decisions of the decision maker affects the system and has
long term effect on it. We also use the same framework we talked about to deal with each
system.
Application 1: Diabetes Screening: In chapter 3, we focus on chronic diseases
specifically diabetes. Type 2 diabetes (which for the sake of simplicity we call diabetes
here) is a major cause of morbidity and mortality worldwide. Diabetes is the 7th leading
cause of death in the U.S. and causes macro-vascular complications, including heart attacks
and strokes, and micro-vascular complications including retinopathy, nephropathy, and
neuropathy (Petersen (2016)). The number of people who have Diabetes worldwide was
estimated to be 221 million in 2010 and is expected to increase to 300 million by 2025 (Bjork
(2001)) In the U.S. 9.4% of the population (30.3 million) have diabetes, 7.2 million of which
are undiagnosed. An additional 33.9% of the population (84.1 million) have prediabetes
of which almost 77 million are undiagnosed (CDCP (2017)). Consequently, diabetes is a
major source of medical expenditures in the form of direct medical costs including hospital
inpatient care (43% of the total direct medical expenditures), prescription medication to treat
the complications caused by diabetes (18%), antidiabetic agents and diabetic supplies (12%),
physician office visits (9%), and nursing/residential facility stays (8%) (Petersen (2016)). In
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the U.S., estimates of direct costs were increasing from $176 billion in 2012 to $237 billion
in 2017 (American Diabetes Association (2018)). Diabetes also imposes high indirect costs
due to work-related absenteeism, reduced productivity at work and home, reduced labor
force participation from chronic disability and premature mortality which increased from
$69 billion in 2012 to $90 billion in 2017 (American Diabetes Association (2018); Bjork
(2001); Petersen (2016)).
Application 2: Emergency Management: In chapter 4, we focus on emergency
management. According to Dallas Fire and Rescue Department, a structural fire incident
needs resources from several fire stations around the city which are close to the incident
location, each providing a specific type of vehicle. This means if more than a single structural
fire incident happens in a small area of a city within a short period of time, no resources
would be available to be dispatched to the incident. This can cause huge damages.
An important question for the Dallas Fire and Rescue Department is whether resources
should be moved around in the city to cover areas where the resources are currently
responding to an ongoing incidence. Every time an incident happens, resources in a particular
zone of the city will be dispatched and become unavailable for several hours. If another
incident happens in that zone during that time, resources from other areas of the city will
need to respond which will increase response time. To mitigate such situations, we can
temporarily reallocate resources.
1.4. Structure of this thesis
In chapter 2, we propose to utilize and combine three techniques and methods in a single
framework to model each system using its key characteristics. In our framework we have a
descriptive model that uses the characteristics of the system’s evolution to model its changes
over time including the inherent uncertainty in the changes. This model is learned directly
from the data available from each application area. We use a prescriptive decision model,
to optimize the decisions and actions the decision maker can make taking into account each
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action’s immediate and long term effects on the system. The decision model provides us
with an optimal policy. Additional information (signals) are provided using the predictive
model. The predictive model is also directly learned from the available data.
In chapter 3, we focus on chronic diseases specifically diabetes. We propose a targeted
screening policy (equivalently, screening strategy) that uses all available information on
individual patients to identify whom to screen (that is, which patients should receive the
gold-standard test) and when to screen them; the policy is also age-specific. We develop
and validate our model on a detailed and proprietary dataset – of over 12,000 patients over
an 18-month period – from a large safety-net hospital and demonstrate, using a simulation
analysis, that our proposed screening policy can improve patient outcomes.
In chapter 4, we focus on emergency management. We apply the proposed framework,
and formulate the problem as a POMDP problem. We focus on one city zone in order to
define our state space. We try to capture the availability of the resources in that zone in
the near future; By implementing the proposed POMDP policy, and through simulation,
we demonstrate that we can improve the average response time by a significant amount
compared to existing policies.
Chapter 5 concludes this thesis. In the appendix of this thesis, details of the simulations




A Data-Driven Decision Framework
We propose to utilize and combine three techniques and methods in a single framework to
create a decision framework that uses data in all main phases. In our framework we have a
descriptive model that uses the characteristics of the system’s evolution to model its changes
over time including the inherent uncertainty in the changes. This model is learned directly
from the data available from each application area. We use a prescriptive decision model,
to optimize the decisions and actions the decision maker can make taking into account each
action’s immediate and long term effects on the system. The decision model provides us
with an optimal policy. Additional information (signals) are provided using the predictive
model. The predictive model is also directly learned from the available data.
Figure 2.1 represent the integration of the methods into a single decision-making
framework. The vertical classification of the methods used in the framework can vary based
on the application but it is strongly related to the perspective the decision maker is looking at
the system from. We will later see how this classification works for each of the applications.
In this work we will use Partially Observable Markov Decision Process (POMDP) as the
main decision-making/prescriptive model (Figure 2.1 upper-right box). The reason behind
choosing POMDP as the main decision model, is the nature of the systems we are analyzing;
the status of each system can be modeled into separate states that change over the time and
these states could be the actual states of a Markov chain. We will elaborate on this later in
each chapter associated with each application.
We use Hidden Markov Models (HMM) as the descriptive model of the systems (Figure
2.1 upper-left box). The role of HMM is to model the evolution or dynamics of the system
in a Markov chain and estimate the parameters of this Markov chain. HMM here provides
the decision model with the parameters of the underlying Markov chain that is being used in
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Figure 2.1: Multi-method decision-making framework to combine descriptive modeling and
predictive modeling with optimization
the POMDP of the decision model. The HMM is directly learned from the historical data.
The predictive model (Figure 2.1 lower-right box) provides the POMDP model with
external information in the form of observations. Below we will see how this predictive
model works in combination with the decision model and how this integration works toward
the contribution of this research.
2.1. Stochastic systems and their evolution
When it comes to decision making under uncertainty, understanding the system for which
we are trying to make an optimal decision is of great importance. Applying rule of thumb
methods is popular when it comes to decision making under uncertainty, but it typically leads
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to suboptimal and often very poor decisions. Systems vary in terms of how they change over
time (how their dynamics work) and where the actual inherent uncertainty comes from.
The way a system changes over time and where the uncertainty comes from impact how an
optimal decision should be made given the current state of the system.
The evolution of many systems over time is continuous but can be simplified into discrete
time-steps with a finite number of states. Including uncertainty, such a system can be
modeled as a discrete-time stochastic process with a discrete state space. Assuming that,
given the current state of such a system the future state of the system is independent of
the past states, the system can be modeled as a Markov chain. If we narrow down the
systems we are dealing with to a system that can be modeled as a Markov chain, then a
set of techniques including Markov Decision Processes (MDPs) or its generalizations such
as Partially Observable Markov Decision Processes (POMDPs) can be applied to determine
optimal decisions. The use of MDPs or POMDPs depends on the nature of the system and
where the uncertainty comes from.
In some systems, the current state of the system cannot be observed directly and thus
is unknown. Only a probabilistic belief of the current state can be constructed using
observations or information coming from the system. POMDPs which are a generalization
of MDPs, allow capturing this type of uncertainty regarding the observability of the current
state of the Markov process. For many applications, the current state of the system is either
unknown or unobservable by the decision maker and this adds to the uncertainty that lies
within the system’s evolution. The two major complications regarding POMDPs are due
to the two types of uncertainty in these types of systems: First, the uncertainty resulting
from the stochastic nature of the system evolution, and second and more importantly, the
uncertainty regarding the current state of the system which has to be inferred via imperfect
information. The second type of uncertainty here is formed by the relation between the
underlying state of the system and the observations produced by the system revealing some
information about the current state of the system.
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Observations used in POMDPs can be any signal that the system emits which gives
information about the actual state of the system. The nature of the observations depends
on the nature of the system. In the tiger problem (Cassandra et al. (1994)) for example, the
decision maker needs to decide which of two doors to open. Behind one door is treasure while
behind the other is a hungry tiger. The decision maker does not know behind which door the
tiger is and can only make observations by listening for tiger noises which are not perfectly
accurate. The question is how often to listen for tiger noises before the decision make opens
a door. The more complex the system is, the more different observations can be made about
the current state of the system. An observation can be a single signal observed at a time or a
combination of signals from different sources within the system. What matters is how much
an observation will help the decision maker to determine the current state of the system and
thus to make the best decisions. Therefore, finding accurate sources of observations from
the system and choosing the best ones is a key step in modeling a POMDP and making the
best decisions.
2.2. Introduction to Partially Observable Markov Decision Processes
POMDPs are generalizations of MDPs where there the state space is not completely
observable to the decision maker (Drake (1962)). A discrete-time POMDP model is a 7-
tuple (S,A,P ,Ω,O, R, λ), where
• S is the set of states (s) describing the various states the system can be in,
• A is the set of available actions (a) the decision maker can take,
• P is the set of transition probabilities between the states which simply describes how
the system evolves over time and is conveying part of the uncertainty in the system
(stochastic dynamics of the system),
• Ω is the set of all observations (o),
• O is the set of observation probabilities or how the observations relate to the actual
states of the system,
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• R is the reward function of the model, and
• λ is a discount factor between 0 and 1.
Figure 2.2: States space and observation space of a POMDP model
The state space and observation space of a POMDP model are depicted in Figure 2.2.
In a POMDP, the states, actions, and observations can be discrete. We denote them at
time by st, at, and ot respectively. Transition probabilities are action and state-dependent
function: P (st+1, st, at) = pr {st+1| st, at}. The observation probabilities are a function
of state, action, and observation: O (at, st+1, ot) = pr {ot|at, st+1}. Since the states are
not directly observable, the decision maker’s belief about the current state of the system is
represented by a belief state πt which is a probability distribution over all possible states. The
belief state is updated using Bayes’ rule every time an action is taken and an observation is
observed: πt+1 (st+1) ∝ O(at, st+1, ot)
∑P(st+1, st, at)πt. The importance of the observations
and their relations with the actual states is given in the belief state update formula based
on Bayes’ rule where the function O is used. The more accurate this function is in terms of
providing information about the actual state of the system, the better is the solution of the
POMDP.
11
At each time step or decision epoch, the decision maker makes a decision and takes an
action available from the action set. The decision maker takes this action based on the
observation. The system then evolves into a new state, new observations are made, and the
decision maker needs to take an action again. Each time an action is taken a certain amount
of reward is given to the decision maker based on the given reward function R (st, at) which
is action and state-dependent.
In POMDPs we are trying to find a set of actions (a policy) that maximizes (minimizes)
the expected total discounted rewards (costs) over an infinite horizon. Such a policy is called
the optimal policy. The optimal policy ℘∗ is obtained by solving the Bellman Optimality
Equation
V ∗ (π) = maxa∈A
{
R (π, a) + λ
∑
o∈ΩO (a, π, o)V ∗(π′)
}
.
The optimal value can be computed by applying dynamic programming to iteratively
improve the value of the function.
Since the belief space is uncountable, the above dynamic programming recursion does
not translate into practical solution methodologies. Even with the finite dimensional
characterization of a POMDP (finite state space, finite action space and finite observation
space), determining the piecewise linear segments of the value function at each epoch is
computationally expensive due to the fact that the number of piecewise linear segments
can increase exponentially with the action space dimension, state space dimension and
observation space dimension. Therefore, exact computation of the optimal policy is only
computationally tractable for small state dimension, small action space dimension and small
observation space dimension. It is shown in Papadimitriou (1987) that solving a POMDP
is a PSPACE-complete1 problem. Littman (2009) gives examples of POMDPs that exhibit
this worst case behavior. It is inferred that simplifying a POMDP model in any way such
1Decision problem A is PSPACE-complete if both of the following are true (Sipser (1997)):
1. A ∈ PSPACE (PSPACE: Decision problems solvable in polynomial space)
2. For every X ∈ PSPACE, X ≤P A.
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as reducing the dimension of any of the spaces including the observation space can save
significant amount of computational expenses. In the next section, we will see how this
problem of interest has been studied in the literature.
2.3. Literature related to Partially Observable Markov Decision Processes
Controlling a Markov process with incomplete state information (including a partially
observable state space) was first studied in Dynkin (1965). The first POMDP model was
developed in Drake (1962). Other researchers at the same time developed finite horizon
POMDPs in the context of stochastic control problems (Aoki (1965); Astrom (1965)).
During the past years many other generalizations and versions of POMDPs have been
investigated and developed by researchers including POMDPs with an uncountable action
space (Sawaragi and Yoshikawa (1970)), POMDPs with Borel spaces (Rhenius (1974)),
POMDPs with an arbitrary core process state space (Furukawa (1967)), non-stationary
POMDPs (Hinderer (1970)), undiscounted infinite horizon POMDPs (Platzman (1980)),
semi-Markov core process PODMPs (White (1975, 1976)), and so on.
There also exists a large number of papers investigating Bayesian control of the sequential
decision process including Furukawa (1967); Rieder (1975); Satia and Lave (1973); Wessels
(1968).
In terms of dealing with observations and the observation space, not much research has
been reported. Most of the studies that utilize POMDPs to solve their problems including
Ayer et al. (2012a); Cassandra (1997); Grosfeld-Nir (1996); Hauskrecht (2000); Littman
(2009); Monahan (1982); Sandikci et al. (2013) simply and naively assume that a single-signal
is apriori known, not considering the fact that real-world systems produce a large number of
signals and that the observation space plays a significant role in POMDPs where the current
state has to be inferred through observations. There exist only a few studies that deal with
how to select multiple observations from a multidimensional observation space. In Hoey
and Poupart (2005) authors speak of multidimensional observation spaces, how to sample
from them, and how to aggregate observations in order to reduce the dimensionality of the
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observation space. Observations can be aggregated in some cases if the policies associated
with them are the same (policy-directed observation aggregation). Observations can also be
aggregated in one-dimensional continuous observation spaces by discretizing the continuum
into segments whose observations yield the same optimal policy (Hoey and Poupart (2005)).
For multidimensional observation spaces, authors in Hoey and Poupart (2005) examine two
approaches. The first approach is for observation spaces where observations are composed
of conditionally independent variables. For this case, they reduce the observation space to
one dimension by sequentially processing the observation variables in isolation. The second
approach which is used for arbitrary multi-dimensional observations is sampling and it is
proved to be an effective approximation technique for computing aggregate probabilities.
The authors in Hoey and Poupart (2005) propose a dynamic partitioning technique which
is integrated with point-based backups. There are several drawbacks associated with these
types of methods. These methods do not work with some POMDP algorithms such as
Incremental Pruning (Cassandra et al. (2013); Zhang and Liu (1996)), Witness algorithm
(Kaelbling et al. (1998a)), and Bounded Policy Iteration (Poupart and Boutilier (2004)).
Another drawback is that the proposed method in Hoey and Poupart (2005) deals only
with POMDPs with continuous observations but discrete states. Although others have tried
to reduce the dimensionality of the whole POMDP by reducing the observation space’s
dimensionality, they have never looked at the problem from a different perspective. All the
efforts that have been made are post-POMDP dimensionality reductions. Here we apply a
pre-modeling technique for observation aggregation that not only produces more meaningful
and accurate observations from the system, but it also shapes both the state space and
observation space in full compliance with each other.
2.4. Predictive Modeling for Observation Aggregation
Observations and their relations to the actual states in POMDPs are extremely important.
Systems may produce more than one signal and these signals can be used as observations in
POMDPs. The question of how to choose the signals to use as observations in a POMDP
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is still open in the literature. If all signals are used as observations, we will have a large
observation space which makes POMDPs very difficult to solve. Even if there is no problem
with the dimensionality, determining the relationship between these many signals and actual
states of the model is not always possible. As mentioned before, reducing the dimensionality
of the observation space by aggregating the observations into more accurate and informative
ones can save significant amount of computational expenses.
The fact that systems produce signals all the time (either continuously or discretely in
time) reveals that the information from these signals gathered over time provides historical
data for the system. If enough data is gathered from the sources of signals (enough signals
recorded), the data can then be analyzed for further purposes using data-driven analytics
techniques. One purpose is to select a subset of signals and aggregating them into a single
more accurate and meaningful observation. This problem is broken down into two major
steps in this research work. The first step is to select a proper subset of signals from the
system (signal selection step). And the second step is to combine or aggregate the selected
signals into a strong observation (signal aggregation step). These two steps are depicted in
detail in Figure 2.3.
The first step is a feature selection problem. We try to select a subset of features (signals)
that are later going to be used in a predictive model to produce more meaningful observations.
From another perspective, using historical data recorded from the signals, in this step we
identify which signals are giving more information about the actual states of the model. The
outcome of this step would be a list of signals, sorted based on their strength in pointing to
the right state of the system.
What needs to be taken into consideration in the signal selection step, is the problem of
missing data. This matters because one type of signal may be accurate, but it might be
harder to observe and thus not always available. We will later see in the signal aggregation
step why this is important.
The signal aggregation step is implemented by a predictive model that uses the selected



































































1 Signal 3 97%
2 Signal 1 73%






























































Figure 2.3: Data-driven signal selection and aggregation framework
accurate. In this step, we develop a classification model where the input is the selected
signals from the signal selection step and the classes are the actual states of the model. By
training this classifier we will have a predictive model that takes all the signals as the input
and then predicts the state of the system. These predictions are then used in the POMDP
as observations to update the belief state.
Predictive models are rarely perfect. There are always misclassification errors associated
with such models. These errors are taken into consideration and used as the relationship
between the predictions (that are going to be used as the observations) and the actual states
of the POMDP. In another word, the accuracy of the predictive model is implemented in the
POMDP as the observation probability function.
Figure 2.3, shows an example system that has a total number of N states (i.e. card(S) =
N) and the system produces M signal at each epoch. Each signal can take N distinct








). This means that in a POMDP model that takes
all these observations into account, the total number of observations would be NM (i.e.
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card(Ω) = NM). Not all these N signal are perfect in pointing to the true underlying state
of the system at each epoch. Some might work better than others. The strong signals are
selected in the signal selection part of the framework. The predictive model then uses these
signals to predict the state of the system. Although the prediction (the outcome of the
predictive model) is in terms of the state of the system, it typically will not be completely
accurate but can be used as an informative observation, increasing our understanding of
what state the system most likely is in. Using the framework in Figure 2.3 we produce only
one signal out of M signals, and this signal can take N distinct values (observations). Thus,




Optimal Individualized Diabetes Screening (P1)
This chapter describes the application of the decision framework to the problem of
diabetes screening. In this chapter, we provide details on the techniques used in the decision
framework in Figure 3.1. We use POMDP to formulate the sequential screening decision-
making problem. The model is informed by the population-specific disease progression
learned from data using the HMM. The disease stages and the costs to the healthcare
system and the patient are derived from the medical literature and clinical expertise. The
screening decisions are highly personalized using a predictive model trained on a large set
of electronic health record data. While any predictive model can be used, we apply here
a logistic regression model with L1 regularization (LASSO). The solution of the POMDP
given the assumptions is an optimal screening policy which can be used in clinical practice.
We propose to supplement existing guidelines with an opportunistic screening strategy
that (1) incorporates all clinical information available about each patient to identify
individuals at higher risks of developing prediabetes or diabetes, and (2) identifies the optimal
time to perform the screening to optimize expected health outcomes and healthcare cost.
Figure 3.1 shows the high-level multi-method framework proposed in this paper. We use
a POMDP model (upper right) to find an optimal policy for the main decision-making
problems of whom to screen and when to screen/re-screen. The transition parameters of
the POMDP model are estimated using a disease progression model (upper left), a Hidden
Markov Model learned from historical patient data. The observations used by the POMDP
model are created via a predictive model that incorporates patient-level risk factors (lower
right).
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Figure 3.1: Multi-method decision-making framework to combine progression modeling and
predictive modeling with optimization
3.1. Background on Diabetes
Like many other chronic diseases, Type 2 diabetes has a prolonged asymptomatic period
during which early detection is possible because diabetes onset occurs on average 9-12
years before clinical diagnosis Lu et al. (2010). Diabetes risk increases across a continuum
with higher glucose levels corresponding to higher risk as the glucose level is an indicator
of whether the patient has diabetes. For diagnostic and treatment purposes, two key
stages are characterized – prediabetes and diabetes. In the prediabetes stage, patients are
asymptomatic and blood glucose is higher than normal but not high enough to be classified
as diabetes. Although progression to diabetes can be reversed by lifestyle modification and
interventions like bariatric surgery, many patients with prediabetes go on to develop diabetes,
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Figure 3.2: the costs associated with the disease increase very quickly as the severity of the
disease increases
a chronic disease requiring medical treatment to control the disease and prevent/manage
complications. Importantly, identification of patients during the prediabetes stage allows
the delivery of evidence-based interventions to delay or prevent the development of diabetes
prevention Program (2008); Group (2002). Thus, screening of individuals at risk for diabetes
and timely surveillance of patients with prediabetes to detect the transition to diabetes is
critical to improving health outcomes and reducing healthcare costs (see Figure 3.2).
Systematic diabetes screening and prevention programs can identify patients at risk for
diabetes and target preventive interventions to delay or prevent the development of type
2 diabetes. The American Diabetes Association (ADA) and the US Preventative Services
Task Force (USPSTF) provide physicians with guidelines for screening. These guidelines
recommend screening about 70% of the population Calonge and Petitti (2008); Care (2013),
which is a very expensive proposition and in many cases, operationally impractical Howard
et al. (2010). The guidelines are based on only a as small number of predictors including
age, body mass index, and a few risk factors. This results in a sensitivity as low as 65%




Figure 3.1 provides an overview of the methods used in this paper to address the problem
of diabetes screening. Many of these methods have been employed independently to answer
specific questions in the healthcare context but they have not been integrated to address
such a decision-making problem. In the following, we review the literature related to these
methods and techniques.
3.2.1. MDP for Medical Decision Making
Markov Decision Processes (MDPs) and Partially Observable MDPs (POMDPs) are
methodological tool of choice to study medical decision making problems for chronic diseases
such as Diabetes (Kuo et al. (1999); Santoso and Mareels (2001); Shih et al. (2007); Hoerger
et al. (2004)), HIV/AIDS (Lee et al. (2014); Gafa et al. (2012); Shechter et al. (2008)),
Cancers (Ayer et al. (2012b); Garćıa-Mora et al. (2010); Ahsen and Burnside (2018); Maillart
et al. (2008); Chhatwal et al. (2010)) and their associated complications (Sandikci et al. (2008,
2013); Schaefer et al. (2004); Sukkar et al. (2012); Alagoz et al. (2010)). MDPs have also been
used for hypertension treatment specifically for designing therapeutic regimens for patients
with hypertension (Zargoush and Daskalopoulou (2018)). Also, MDPs have been used for a
wide range of healthcare management problems such as dealing with emergency department
congestion (Patrick (2011)). An attractive key feature of MDPs is that they can be used to
deal with sequential decision-making problems in contexts with large levels of uncertainty
(for example, in terms of how fast the disease progresses in a given patient population). In
such settings, MDP’s can be used to determine the optimal time for screening and treatment
initiation (Alagoz et al. (2010)). For example, MDPs have been used to answer questions
such as: optimal time to initiate antiretroviral therapy in HIV patients (Shechter et al.
(2008)), optimal time for breast cancer screening in women (Maillart et al. (2008); Chhatwal
et al. (2010); Ayer et al. (2012b)), or optimal time for accepting a living-donor transplant
in patients suffering from end-stage liver disease (Alagoz et al. (2004, 2005); Sandikci et al.
(2013, 2008)). Readers are directed to (Alagoz et al. (2010); Monahan (2008); Cassandra
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(1997); Schaefer et al. (2004)) for a review of literature describing uses of MDPs in medicine.
3.2.2. HMM to Model Disease Progression
Disease progression modeling is important for disease prognosis improvement, drug
development, and clinical trial design. Difficulties with modeling disease progression
include progression heterogeneity (patients have different progression trajectories due to
many reasons), incomplete patient records (censoring and missing information), discrete
observations (disease progression is a continuous process, but patients’ records of the
progression are observed and recorded at discrete times with varied intervals), and
irregularity of observations (due to irregular visits) (Wang et al. (2014)).
A large portion of the literature on disease progression modeling focuses on evidence-
based modeling using machine learning and statistical techniques based on observational
data. A popular model is the hidden Markov model, where disease progression is modeled
as a progression through a set of unobservable discrete disease states governed by transition
probabilities. For example, a general hidden Markov model to estimate transition rates
between states as well as the probabilities of states of misclassification is presented in Jackson
et al. (2003). Another study (Liu et al. (2015)) presents an effective learning method for
continuous-time HMMs by dealing with the challenges of estimating the posterior state
probabilities and the computation of end-state conditional statistics. In Sukkar et al. (2011)
the authors develop a six-state HMM of Alzheimer’s disease which allows progression by one
or two states or regression by one state using data from 595 subjects. They calculate the
states transitions and conditional probabilities of being in each state using the developed
model. The authors also propose an HMM for the Alzheimer’s progression in another study
(Sukkar et al. (2012)) with the ability to identify more granular disease stages than the three
currently accepted clinical stages for Alzheimer’s disease. Some studies use techniques other
than HMMs to model the disease progression or obtain state transitions such as simulation
(Lee et al. (2008)). Best practices on estimating the transition rates between states including
techniques such as HMMs can be found in Denton (2018); Siebert et al. (2012).
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3.2.3. Predictive Models in Healthcare
There is a growing number of studies using predictive models in healthcare decision
making. These studies include the use of analytics in healthcare such as personalized diabetes
management (Bertsimas et al. (2017)), chemotherapy regimens for cancer (Bertsimas et al.
(2016)), hospital readmissions (Shams et al. (2015)), and healthcare screening decisions such
as screening for Hepatocellular Carcinoma (Yuen and Lai (2003)), breast cancer screening
(Maillart et al. (2008)), and HIV screening (Deo et al. (2015)). Studies on the use of
predictive models for diabetes screening are reviewed in (Collins et al. (2011)) where the
authors conduct a systematic review of the methodology of 39 studies and in (Jahani and
Mahdavi (2016)) where the authors develop neural network models for diabetes prediction
and compare with other models.
(Collins et al. (2011)) survey 39 studies with 43 risk prediction models that use 4 to 64
predictors including age, family history, body mass index (BMI), hypertension and fasting
glucose. The most common modeling method among these studies is logistic regression. It
is reported, that almost all reviewed studies remove incomplete cases or do not mention
how missing data are treated. There are two types of predictive model in the literature,
single-factor and multi-factor models. The single-factor models use common predictors such
as age or BMI for which the availability in routine clinical settings is high. The drawback for
single-factor predictive models is that no prediction can be made if the factor is not available
for a patient. On the other side, for multi-factor models, can incorporate many factors, but
since all these factors need to be available for the patient, for the sake of practicality a small
number of predictors is typically preferred. Multi-factor models consider more information
about the patient and therefore can provide better predictions compared to single-factor
models.
The majority of the reviewed literature focuses on using a only single technique of the
multi-method framework proposed in Figure 3.1. While these methods individually can
be used to predict desease progression at the population level or what patients are more
at risk of having undiagnosed diabetes, they only. . . The key contributions of this paper
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is that we group all these methods and techniques together, using one to feed another,
feeding all with real data to answer a question that has implications for clinical practice
as well as contributions to a theoretical operations literature. Researchers have used the
same techniques but independently, they have used MDPs or POMDPs to model decision
making problems that concern healthcare but independent of what a specific hospital system
would need or without using real data. They current state of the art is to simply assume
some transition rates while we actually calculate using real data. They have used HMMs
to estimate transition and progression rates for various disease but not in the context of a
decision making problem. They have used data driven methods including predictive models
to predict specific chronic diseases such as diabetes but never used it to feed MDPs as
an individualized input for the decision making problem. . . . our approach is able to
answer the questions of whom to screen, when to screen them and how often rescreening
should take place in an integrated, analytics-driven decision framework that takes health
outcomes, healthcare cost, cohort information, and available individual patient information
into account.
3.3. The Partially Observable Markov Decision Process Formulation
Partially Observable Markov Decision Processes (POMDP) are an extension of Markov
Decision Processes (MDP) to make optimal decisions when the current state of the system
(in our case, the true health status of the patient) is not directly observable. The method
uses a probabilistic belief distribution over the unobservable states of the system which is
informed by observations. These Markov models assume that the process is Markovian, i.e.,
that future states only depend on the current state. While this is a very strong assumption,
models based on the assumption are often very useful.
The set of states for the screening decision model are healthy, prediabetes, and diabetes.
The decision is whether to screen the patient, henceforth referred to as “screening” decision.
We assume the following: (a) the decision-maker is the clinician who acts on behalf of the
patient and the health system, (b) the screening decision for a given patient is independent
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of other patients, (c) screening decisions are made at discrete points in time when the patient
and clinician meet, and (d) patients stay in each state for at least one decision epoch.
A discrete-time POMDP model is a 7-tuple (S,A, P,Ω, O,R, λ), where S is the set of
states, A is the set of actions, P is the set of transition probabilities between the states, Ω is
the set of all observations, O is the set of observation probabilities, R is the reward function
of the model and λ is discount factor. Below are the detailed description of the essential
components associated with the POMDP that need to be defined in advance to model the
problem Cassandra et al. (1994); Kaelbling et al. (1998b); Puterman (2005):
3.3.1. Time Horizon and Decision Epochs
We use decision epochs of one year. Decisions are made at the beginning of each period
starting from the first time the patient meets the clinician. We represent the epochs with
t = 0, ..., T . The time horizon in our problem expands from the first time the patients meets
the clinician until the patient dies or reaches the age of 79.
3.3.2. State Space
The state space in our model consists of a total of 7 distinct states S =
{H,P,D, SH, SP, SD,∆} and includes both observable and unobservable states. The 3
unobservable states are: Healthy (H), Prediabetes (P), Diabetes (D) which are the main
underlying stages of diabetes. The 3 observable states are the screened representatives of
the observable states: Screened Healthy (SH), Screened Prediabetes (SP), Screened Diabetes
(SD). These states are completely observable, since they are the outcome of screening. The
last state is Death (∆), which is the absorbing state.
3.3.3. Action Space
The action space, A = {S,N}, represents the decision to screen (S) or not to screen (N)
a patient. We use at ∈ A to denote the action that is taken at time t at each decision epoch.
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3.3.4. Transition Probabilities
These probabilities indicate the probability of a patient moving from the current state
(st) to another state (st+1), given action at is taken. This probability is denoted by p{st+1 |
st, at}. These transition probabilities are associated with the arcs on the Markov model
underlying the POMDP (depicted in Figure 3.3). We use P to represent the set of all
transition probabilities (typically one state-to-state transition matrix per action). Regression
from diabetes to prediabetes or healthy states is very unlikely we therefore do not include
an arc from state D to P or D to H, corresponding to a transition probability of zero.
For our model, we assume that the transition probabilities are stationary in the considered
cohort. Thus, we drop the index t and use the notation p{s′ | s, a} to denote the “stationary”
probability of transitioning to state s
′
given the current state is s and action a is taken.
A key characteristic of the transition probabilities is that the sum of the probabilities of
transitioning from the current state to all other states including the current one should be
equal to 1 for each single action; that is
∑
s′∈S
p{s′ | s, a} = 1, for all s and a. (3.1)
We have the following:
p{H | H,N} = 1−
∑
s′∈S−{H}
p{s′ | H,N} = 1− p{P | H,N} − p{D | H,N} − p{∆ | H,N},
(3.2)
Similarly, for states P and D we have:
p{P | P,N} = 1−
∑
s′∈S−{P}
p{s′ | P,N} = 1−p{H | P,N}−p{D | P,N}−p{∆ | P,N}, (3.3)
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and
p{DH | D,N} = 1−
∑
s′∈S−{D}
p{s′ | D,N} = 1− p{H | D,N}− p{P | D,N}− p{∆ | D,N}.
(3.4)
We assume that a positive screening result (i.e., the patient is diagnosed with prediabetes
or diabetes) influences the patient. The patient will receive medical treatment or may
perform lifestyle changes (e.g., diet, exercising, weight loss). We capture these effects using
the factors β, γ ∈ (0, 1) which are used to reduce the transition probabilities for the disease
to progress from screened states (SP, SD) into more severe stages compared to patients in
the same states but not screened.
3.3.5. Observations and Observation Probabilities
At each decision epoch, a signal/observation, o ∈ Ω, provides information about the true
underlying (unobservable) state of the patient. Depending on the nature of the problem,
observations can be obtained from various sources. We propose to create these observations
using a predictive model (see Section 3.4) which classifies the patients into the groups of
Predicted as Healthy (PH), Predicted as Prediabetic (PP) and Predicted as Diabetic (PD).
Thus, the observation space is Ω = {PH,PP, PD}. Predictive models are usually not
perfect and therefore the predictions used as observations are probabilistically connected to
the unobservable states, i.e., the probability associated with predicting a specific observation
o ∈ Ω, given that the true state of the patient is s is O(o | s) where O is the set of all
observation probabilities.
3.3.6. Belief States
Π(S) is the probability simplex over the state space S, defined as Π(S) = {π ∈ R3 :∑3
i=1 πi = 1, πi ≥ 0,∀i}, also called the belief space Sandikci et al. (2013); Brafman (1997);
Sandikci et al. (2010). We use πt to denote the belief state at period t which is the probability
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distribution over the set of possible states, i.e., πt = (πt(H), πt(P ), πt(D)).
3.3.7. Reward Functions
The POMDP maximizes expected rewards. Taking action a while being in state s will
bring about an immediate reward denoted by the reward function r(s, a). We use as the
values of the reward function estimates that combine the patient’s QALY (Quality Adjusted
Life Year Neumann et al. (2014b) ), the costs of prediabetes, diabetes and screening tests all
measured in US dollars. We formulate each state-and-action specific reward function from
the societal perspective as follows:
r(s, a) =

Q , s = H, a = N
(1− αP )Q, s = P, a = N
(1− αUD)Q, s = D, a = N
Q, s = SH, a = N
(1− αP )Q, s = SP, a = N
(1− αDD)Q, s = SD, a = N
(Q− CS)ur, s = H, a = S
(1− αP )Q− CP − CS, s = P, a = S
(1− αDD)Q− CD − CS, s = D, a = S
(Q− CS)ur, s = SH, a = S
(1− αP )Q− CP − CS, s = SP, a = S
(1− αDD)Q− CD − CS, s = SD, a = S

(3.5)
where the terms Cs, CD, CP , Q, le, ld, ur, Q and αi, i = {P,UD,DD,D} are later described
and estimated in Table 2 in section 4 alongside their values.
3.3.8. Bayesian Belief State Update and Optimality Equation
To implement learning from a new observation o, the belief state π = (π(H), π(P ), π(D))
is updated to π
′













′ | s′)∑s∈S p{s′ | s, a}π(s)∑
s′∈S O{o′ | s′}
∑
s∈S p{s′ | s, a}π(s)
(3.6)
Using belief states, the POMDP can be reformulated as a continuous state MDP and the
optimal solution is the result of solving the Bellman optimality equations Puterman (2005):







p{s′ | s, a}O{o′ | s′}ν(s′ , π′)} (3.7)
where λ ∈ [0, 1) is the discount rate. The result will be the optimal screening program
suggested by the model (see Section 5).
Figure 3.3: Underlying health states and observations of our POMDP model and the
transitions among them. Only possible transitions are shown and those, which are not likely
such as the transition from Diabetic to Healthy, are not depicted. Black arcs correspond to
the natural progression of disease, green arcs correspond to the screening decisions, and red
arcs correspond to reversion from screend states to uncontrolled ones.
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3.4. Hidden Markov Models
A significant issue with using models that are based on transitions between unobservable
states is how to estimate transition probabilities reliably from data. In our case, the states
H,P,D are not directly observable, but the POMDP models needs transition probabilities
between these states. The available data are provided by patient histories where at some
point in time a diagnosis of prediabetes or diabetes is made, typically via a HbA1c screening
lab test. We assume that up to the point in time when the diagnosis is made no significant
medical intervention is performed and that the lab test reveals the true state (with some
error). Transition probabilities between the unobservable states can be estimated from such
data using a Hidden Markov Model (HMM), where the word hidden is used here for the fact
that the true disease states are unobservable.
A HMM is a sequence of random variables Xt for time t = {1, 2, ...} representing the
hidden state with 3 possible values H,P,D and a sequence of associated random variables
Yt whose realizations of the 3 possible values SH, SP, SD represent observations. There are
two types of parameters associated with HMMs: the transition probabilities between two
unobservable states given by the transition matrix
M = {mij} = P (Xt = j | Xt−1 = i), (3.8)
and the probabilities that indicate the likelihoods that a certain hidden state will lead to a
specific observation in the form the emission probability matrix
N = {nj(yt)} = P (Yt = yt | Xt = j). (3.9)
The initial state distribution for t = 1 is defined as qi = P (X1 = i). The aim is to
estimate the parameters of the hidden Markov chain, σ = (M,N, q) from observational data.
The standard estimation procedure for HMMs is the Baum-Welch algorithm which utilizes
the Expectation–Maximization iterative algorithm in order to find the maximum likelihood
estimate of the parameters of the model given a set of historical observations Huang et al.
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(2001). The transition matrix M provides a data-driven estimate for the transitions between
the unobservable states in the POMDP specific to the cohort under consideration.
3.5. The Predictive Risk Model
Predictive risk models are powerful tools that can contribute to the decision-making
process especially in the field of medical decision making. PRMs are usually multivariable,
using several patient risk factors that are used to predict an outcome such as patient’s status.
These models can be utilized in many different ways including identifying those who are at
an increased risk of having an undiagnosed condition to target healthcare interventions or
lifestyle changes to.
Instead of using different risk factors directly in the update of the belief state in the
POMDP, we propose to use a predictive risk model (PRM) to generate personalized
predictions (used as observations) for the POMDP. Using a PRM offers many attractive
features including a wide selection of available classification methods, a simple and efficient
learning process, the possibility of data-driven feature selection, and the availability of
methods that deal with missing data. These are very important advantages for working with
electronic health record data, where the amount of information available for each patient
can vary substantially.
The PRM model is used to predict one of the K = 3 values for the response variable
G = H,P,D using a feature vector x. Here we consider multinomial regression, an extension
of logistic regression for a response variable with multiple levels. The probability of value k
is predicted by










and the value with the highest probability is used as the prediction. The parameters are






l(yi, β0k + β
T
k xi) + λ ‖ β ‖1, (3.11)
where the function l calculates the negative log-likelihood contribution of observation i, and
the last term is used for L1 regularization.
Predictive models make classification errors. For example, a healthy patient may be
misclassified as having prediabetes. These errors can be assessed using standard cross-
validation techniques and are typically summarized in a so-called confusion matrix. Since
we use predictions as observations o and the correct classification is given by the unobservable
state s, the confusion matrix can be used as an estimate for the observation matrix O.
3.6. Parameter Estimation
In this section, we will first describe the data used in this research, and then we provide
explanations on how we estimated each set of parameters using the techniques previously
introduced and described in this chapter.
3.6.1. Data Description
The data used in this part of the research comes from the Electronic Health Record (EHR)
of a large, integrated safety-net health system. Our cohort consists of patients from the
Parkland Health & Hospital System, who are at risk for diabetes but have not been diagnosed
with diabetes at the time of cohort entry. The cohort period is 2010 to 2014, during which
individuals in the cohort may be diagnosed with diabetes. We retain patients, who have been
diagnosed with diabetes, follow them over time, noting that additional information has been
collected on them after their diabetes diagnosis. The cohort includes established primary
care patients with an index visit occurring between January 1, 2012, and June 30, 2013,
and 2 or more completed outpatient visits between the index visit and December 31, 2014.
Patients are between 18 and 64 years of age at cohort entry. We exclude prevalent diabetes
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Table 3.1: Key characteristics of the cohort studied
Entire Cohort (N=12071) Normal Glycemia (N=4883) Diabetes (N=1314)
Age, years (SD) 47.49 (10.5) 45.18 (11.1) 50.02 (8.9)
Female, % 69.9 69.8 68.2
Race/ethnicity Non-Hispanic White 13.3 15.2 10.2
Black 39.8 35.2 44.7
Hispanic 42 45 40.4
Other 4.9 4.7 4.7
Education, years, mean (SD) 8.73 (3.3) 9.06 (3.2) 8.15 (3.4)
BMI, kg/m2, mean (SD) 31.37 (7.4) 29.74 (6.8) 35.2 (8.1)
Primary payer, % Charity 40 39 41.7
Private 13.2 13.1 11.8
Medicare/Medicaid 26.7 25 31.2
Self-pay 20 22.6 15.3
Lab values, mean (SD) Random Glucose 97.48 (17) 93.16 (12.9) 112.4 (27.3)
HDL-C 51.74 (15.5) 53.65 (15.5) 47.57 (13.8)
LDL-C 193.52 (38.6) 190.95 (38) 195.87 (39.4)
Triglycerides 146.35 (99.4) 135.52 (86.6) 173.62 (136.3)
Systolic BP 129.11 (15.7) 126.01 (15.6) 135.44 (15.5)
White Blood Count 7.39 (2.7) 7.34 (2.7) 7.71 (2.2)
Ferritin 140.06 (322.1) 140.26 (360.3) 150.95 (312.7)
Tobacco User, % Yes 12.2 12.8 12
Never 69.5 71.3 66.1
Passive 1.8 1.9 1.7
Quit 16.4 14 20.1
Alcohol User, % 10 9.9 10.2
Family history DM, % 71.1 74.8 62.1
Hypertension, % 46.9 38 62.6
CHF, % 2.3 1.7 3.8
Cardiovascular Disease, % 22.8 17.8 29.5
Medication use, % Steroids 18 18.6 17.6
Anti-hypertensives 45.5 37.4 61.5
and gestational diabetes. We excluded patients diagnosed with diabetes and prediabetes on
or 18 months before the index visit using ICD-9-CM encounter codes, problem list diagnoses,
and laboratory results (A1c, fasting glucose, oral glucose tolerance tests) meeting diagnostic
criteria . Table 3.1 provides summary statistics.
We estimate various parameters of our model using the data described in Table 3.1. We
reiterate that our goal is to provide an age-specific screening policy; some parameters such
as mortality rates are estimated for various age ranges.
3.6.2. Estimating Transition Probabilities
We estimate the transition probabilities for the POMDP, using patients’ historical data
(screening results from the EHR) as an input for the HMM. Screening results can be subject
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to error and thus the true health status of the patients is not observed directly but through
realizations or observations which are the LAB results. These trajectories are all discrete
observations recorded irregularly in time with varied intervals (due to irregular visits) and
are not always complete. The trajectory (P,*,*,*,*,P,*,*,D,*,D) can be an example of a
sequence of observations for a single patient during 11 years where * are representatives of
missing values (the years at which the patient did not show up or was not screened).
HMM uses the above-mentioned trajectories as an input for an iterative algorithm and
tries to find the transition probabilities that best fit the input sequences. The outcome of




0.9438 0.048 0 0.0082
0.0328 0.9242 0.0348 0.0082
0 0 0.9916 0.0084
0 0 0 1

(3.12)
Note that it is impossible to go directly from Healthy to Diabetic since all the patients will
experience prediabetes by definition before getting into diabetes. There is also no regression
from diabetes to prediabetes and as soon as the patient gets into diabetes will have to stay
there.
The three elements of the matrix P that cannot be estimated from our data are age-
specific mortality rates for healthy, prediabetes and diabetes states. We obtain this from
the National Center for Health Statistics that reports the age-adjusted death rate of 0.0072
(2016 numbers) for standard population considering all possible causes of death Kochanek
et al. (2016) . We also estimate the age-specific death rates for age groups starting from 15
as well as the mortality rate for diabetes for the total population.
In order to estimate the age-specific mortality rates we define three random variables X,
Y ,and Z, where X is the random variable indicating the age of the patients in the cohort, Y is
the random variable representing the age at the death of the patients, and Z is the difference
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between these two random variables, i.e. Z = Y −X. Based on Kochanek et al. (2016) the life
expectancy for the U.S. population in 2016 is 78.6, i.e. E[Y ] = 78.6. Also from our dataset
we have E[X] = 47.5 (Table 3.1). Thus E[Z] = E[Y −X] = E[Y ]−E[X] = 78.6−47.5 = 31.1
would be the expected remaining life for the whole cohort. The quantity of interest is actually
p{Z = 1} = P1 for each specific age that translates into the mortality rate per each year
assuming the mortality rate is stationary. Thus, we have:
p{Z = n} = (1− P1)n−1P1, (3.13)
assuming each year is independent of other years. (3.13) is the probability distribution
function (pdf) of the Geometric distribution where Z is the number of independent trials
until a failure occurs (in this case, death). Thus, based on the Geometric distribution,
E[Z] = 1/P1. This way we can calculate the death rate per year P1 for each age assuming
E[Y ] = 78.6 using E[Z] = E[Y −X] = E[Y ]−E[X] = E[Y ]−X. We calculate this rate for
healthy, prediabetes and diabetes patients and show them with P(1, H), P(1, P ), and P(1, D)
respectively. It is worth highlighting that the life expectancy, E[Y ], varies for patients with
diabetes. Based on a 2010 report by the Diabetes UK, type 2 diabetes reduces the lifespan
by 10 years Key statistics on UK (2010). Another study claims that for people over 55, type
2 diabetes reduces lifespan for an average of 6 years for women and 5 years for men Loukine
et al. (2012).
3.6.3. Estimating Observation Probabilities
We extracted more than 40 features from the electronic health records and addressed
missing data using multiple imputation de Goeij et al. (2013). All features are scaled to
z-scores and multinomial regression with L1 regularization is applied. Table 3.2 gives the
parameters for the strongest 10 predictors converted to odds-ratios for the class diabetes
against health and prediabetes. The AUC column shows the area under the receiver
operating characteristic curve (diabetes against healthy and prediabetes) achieved by adding
more and more features.
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Table 3.2: Top 10 features of the proposed regularized multinominal regression model
Feature OR AUC
MEAN RANDOM BLOOD GLUCOSE LEVEL 1.67 65.53%
BMI 1.40 68.50%
SYSTOLIC BP 1.14 71.17%
HYPERTENSION 1.04 72.10%
FAMILY HISTORY 1.19 72.10%
HIGH DENSITY CHOLESTEROL 0.85 72.60%
AGE 1.19 72.87%
BLOOD PREASURE MEDICATION 1.06 72.87%
CHOLESTEROL MEDICATION 1.09 73.15%
CHOLESTEROL HDL RATIO 1.02 73.42%
The observation matrix O needed by the POMDP is estimated using the risk model’s
confusion matrix obtained via ten-fold cross-validation. For example, the observation
probability that a healthy patient will be classified as having prediabetes O(P,H) is the
estimated classification error of the model. The estimated observation matrix is given as
follows.






The observation matrix for a perfect predictive model would have a probability of 1 along
the diagonal of the matrix and zero otherwise.
3.6.4. Estimating Rewards
Table 3.3 lists the values for these parameters and the cost of a diabetes screening test in
the U.S. All reward parameters and constants are annual and are based on estimates found
in the literature (see column source in the table). All costs are estimated from the societal
perspective.
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Table 3.3: Parameters associated with the reward function of the POMDP model
Parameter Description Source Value
Cs Cost of a diabetes screening test Chatterjee et al. (2013); Zhang et al. (2003);
O’connor et al. (2001); Kahn et al. (2010)
$8,346 1
Q Quality-Adjusted Life Year in U.S. dollars Neumann et al. (2014a) $50,000
CD Direct medical costs per year for a new-onset diabetes Chatterjee et al. (2013) $4,174
CP Incremental direct medical costs per year for
a patient with prediabetes
Chatterjee et al. (2013) $1,316
αP Annual utility decrease of living with prediabetes Ackermann et al. (2009); Neumann et al. (2014a) 0.16
αUD Annual utility decrease of living with undiag-
nosed diabetes
Ackermann et al. (2009); Zhang et al. (2012a);
Bahia et al. (2017); Zhang et al. (2012b)
0.2
αDD Annual utility decrease of living with diag-
nosed diabetes
Ackermann et al. (2009); Zhang et al. (2012a);
Bahia et al. (2017); Zhang et al. (2012b)
0.18
mT Age-Adjusted mortality rate in U.S. in 2016 Kochanek et al. (2016); Murphy et al. (2015) 0.0084
mD Age-adjusted mortality rate for Diabetes in 2016 Kochanek et al. (2016); Murphy et al. (2015) 0.00021
le Life expectancy for the U.S. population in 2016 Kochanek et al. (2016) 78.7
ld Lifespan decrement due to Diabetes Loukine et al. (2012) 5
ur Uptake rate of Diabetes screening
2 Khunti et al. (2015); Park et al. (2008); Orton
et al. (2013); Davies (1999); Eborall et al.
(2012)
0.644
3.7. Optimal Screening Policy3
There are various algorithms to solve POMDP problems. Details on how to solve
POMDPs and a survey on POMDPs solution methods are beyond the scope of this research
and can be found in Lovejoy (1991a,b). In this paper we will apply a popular grid-based
approximation Hauskrecht (2011); Ahuja and Birge (2018) called the finite grid method
Sandikci et al. (2013); Cassandra and Rocco (1998).
When the solution of the POMDP problem converges, then we can create a finite state
controller from the value function’s partitioning of the belief space. Using this controller, the
decision maker can execute the optimal policy without the need to track the actual belief
states. The controller is a graph where nodes are representatives of the belief states and arcs
represent updates of the belief state due to new observations. As an example of this graph,
the optimal policy for patients of age 55, solved with a coarse grid is depicted in Figure 3.4.
We use a coarse grid, since it results in a smaller number of belief states and a graph that
is easier to visualize and interpret. The initial node is determined by the prior belief about
the health status of the patient. For example, assuming that the prevalence of diabetes and
prediabetes among the patients in our cohort is 10 percent and 20 percent, respectively, the
3The authors of this paper have also developed an R (Team (2018)) package called “pomdp” which
provides an interface to pomdp-solve, a solver for Partially Observable Markov Decision Processes (POMDP)
Kamalzadeh and Hahsler (2019)
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Figure 3.4: Policy graph for patients of age 55 solved with a coarse grid
initial belief state will be π1 = (π1(H) = 0.7, π1(P ) = 0.2, π1(D) = 0.1) or node 6 in Figure
3.4. In other words, the decision maker will assume, based on the existing prevalence rates
(and with no other information) that the patient is in node 6 when she shows up for the first
time. As additional information on a patient becomes available (e.g., blood pressure, BMI
or symptoms of a DM complication), the predictive model will create a prediction which
is used as an observation to update the beliefs, or in other words, the state of the world
(represented by nodes) changes. We have arranged the graph such that the belief about
the decease severity increases from right to left and Predictions as Healthy (PH) move the
patient to the left, while Predictions as Diabetic (PD) move the patient to the right.
The only belief state where the optimal action is screening is state number 3. From there
the patient can go to the best state 9 (screened healthy), state 1 (screened diabetic), or stay
in state 3 (screened prediabetic). This implies that the optimal choice for patients of age 55
that are screened as prediabetic is to rescreen them in the next period since they remain in
the screening state.
By using a finer grid, we can create decision graphs with many more belief states, however,
the visualization of the decision graph becomes more and more difficult to read. We can
visualize the belief space as a ternary plot and place a belief states in that space. Figure 3.5
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(a) shows how a single belief state is located in the plot. Figure 3.5 (b) shows all the belief
states using a very fine grid for patient of age 55. Belief states where the optimal action
is screening are colored red. It can be seen that the decision boundary between screening
and not screening states can be approximated by a straight line through the belief space.
The patient should be screened whenever the belief about the patient’s health falls below
the line. A patient can be assigned to a belief state that indicates screening because the
physician makes that determination during the first encounter or because the belief state for
an existing patient is updated due to high-risk observations created by the PRM.
Since prevalence of diabetes is age dependent, also the optimal screening policy is age
dependent. We calculate the optimal policy graphs for different age groups, find the linear
separation between screening and not screening states and just place the linear separation
lines in the Figure 3.5 (c). As the patient’s age increases the decision boundaries move upper
from the triangle base. This indicates that the model is trying to reduce the risks as the
patients get older. For example, it is not optimal to screen a 60 years old patient with a belief
state of (40, 50, 10), but the same patient should be screened the next year. It shows that
as the age increases, the model moves the screening thresholds in a way that even patients
with lower risks get screened. For ages above 71, the policy the model provides is to screen




(a) how to read the graph
screen
not-screen
(b) decision boundary for age 55
(c) decision boundaries for various ages
Figure 3.5: Ternary plots representing the decisions associated with each belief state.
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3.8. Policy Implications And Evaluations
3.8.1. Simulation Model for Guidelines Evaluation
There exists a vast literature on comparing different screening policies using cost-
effectiveness analysis Howard et al. (2010); Kahn et al. (2010); Chen et al. (2001); Chatterjee
et al. (2013); O’connor et al. (2001); Hoerger et al. (2004). Most of the studies simulate a
cohort of patients with specific parameters provided to evaluate the cost-effectiveness of either
mass screening or opportunistic screening for type 2 diabetes. We apply here simulation to
evaluate the effectiveness of the proposed screening policy and to compare it with existing
screening guidelines. To simulate the natural progression of diabetes and its complications
including retinopathy, nephropathy, and neuropathy we use the Markov models shown in
Figure 8 and developed in Chen et al. (2001). Each node in the graphs represents one stage
of disease, and the stages are arranged from least to highest severity as one goes from left
to right. The costs associated with each stage of thee complications are taken from Howard
et al. (2010); Chen et al. (2001).
The simulation consists of a hypothetical cohort of 50000 patients whose characteristics
have been described previously in Table 3.1. Parameters such as transition probabilities in
disease Markov models, utilities and costs, incidence, prevalence and mortality rates of each
state of the disease progression models used in this paper are all taken from Chen et al.
(2001); Kahn et al. (2010); Howard et al. (2010). We simulate seven different scenarios
representing different screening policies including the proposed screening policy. Patients
leave the simulation when they die or when they reach the maximum life expectancy. For
the opportunistic screening policy, the patient’s chance of getting screened or diagnosed with
prediabetes, diabetes or its complications is limited by the number of times they visit the
physician, either randomly for a blood test or due to observing a symptom of a complication,
as in the case of existing guidelines. We also assume that early detection and treatment
of prediabetes can lead a patient back to a healthy state again and reduces the chances
of progressing into diabetes. Also, early detection and treatment of diabetes can reduce
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(a) Retinopathy: {NDR: No Diabetic Retinopathy, NPDR: Non-proliferative Diabetic Retinopathy,
PDR: Proliferative Diabetic Retinopathy, ME: Macular Edema, B: Blindness}
(b) Nephropathy: {NNP: No Nephropathy, MA: Microalbuminuria, PR: Proteinuria, ESRD: End
Stage Renal Disease, CVD: Cardo Vascular Disease, DE: Death}
(c) Neuropathy: {NNR: No Neuropathy, SNR: Symptomatic Neuropathy, LEA: Lower Extremity
Amputation}
Figure 3.6: Markov models for natural disease progression of diabetes complications
the patient’s chances of developing complications or progressing into more severe stages of
complications.
A detailed description of the conducted simulation can be found in the appendix.
3.8.2. Guidelines Evaluation
To compare the outcomes of the different simulated scenarios and thus the efficacy of the
proposed policy with other screening policies, we report the metrics used in the literature.
These metrics include ICER (incremental cost-effectiveness ratio), years gained, QALYs
gained, diagnosis lead time, macrovascular events prevented, microvascular events prevented,
and deaths prevented Chen et al. (2001); Kahn et al. (2010). To calculate the ICER, each
systematic policy is compared with an opportunistic screening policy. Table 3.4 reports the















































































































































































































































































































































































































































































































































































































































































































































Table 3.4 shows that the proposed policy, SP-POMDP, performs better than all other
policies in every metric except for the maximum screening policy, SP30-1. Compared to
opportunistic-screening, SP-POMDP diagnoses prediabetes and diabetes patients on average
18 years earlier while this is only outperformed by the maximum screening policy. In terms
of macrovascular events, microvascular events and deaths prevented, although the maximum
screening policy produces slightly better simulation results compared to SP-POMDP, there
is not a significant difference between POMDP and the maximum screening guideline. SP-
POMDP achieves very similar outcomes to SP30-1, but reduces the cost per gained QALY
significantly from more than $36,000 to less than $20,500.
(a) (b)
Figure 3.7: (a) Costs per QALY and (b) cost per years gained of seven screening guidelines
compared with opportunistic screening in terms of QALYs and years of life gained. The
efficient frontier is shown as a line.
Figure 3.7 compares the screening policies in Table 3 using the notion of the efficient
frontier. Figure 3.7 shows that the efficient frontier is comprised of SP30-1 (maximum
screening), SP-POMDP, and SP60-3, indicating that all other policies are inefficient. The
SP-POMDP is slightly inferior to SP30-1 but it takes significantly less resources, less time
from the patients, less lab tests, and cause less stress for patients.
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3.8.3. Sensitivity Analysis of the Simulation Model
To evaluate the sensitivity of our model to the parameters introduced in Table 3.3, we
performed two different sets of sensitivity analyses. The first set is designed to evaluate
the sensitivity to the cost parameters including the cost of the diabetes screening test Cs,
the annual utility decrease of living with prediabetes αP and the annual utility decrease of
living with diabetes αUD, αDD. The second set is designed to evaluate the sensitivity to
the probabilities including transition probabilities P and observation probabilities O. The
same output measures as in Table 3.4 are used to evaluate the sensitivity of the model to
these parameters. Table 3.5 shows the result of the performed sensitivity analysis.
Table 3.5 shows that the proposed SP-POMDP model is robust with respect to most
parameters. The model is sensitive to the costs of screening which affects cost-effectiveness,
QALYs gained, and diagnosis lead time. As we expect, the higher the cost of screening,
the less cost-effective (higher ICER) the policy would be and the opposite. As the cost of
screening increases the proposed model move toward postponing the screening as much as
possible which results in lower QALYs gained and an increase in diagnosis lead time.
The value of a QALY affects the policy with lower values of a QALY representing a
lower rewards in the POMDP reward structure which will result in postpone screening to
accumulating more costs and gaining fewer QALYs as well as decreasing the diagnosis lead
time. On the other hand, higher values of QALY translates into higher rewards in the
POMDP model which in turn translates into more cost-effective policies with more QALYs
gained and longer diagnosis lead time.
Table 3.5 also shows that higher screening uptake rates also result in more cost-effective
policies with more QALYs gained and longer diagnosis lead time. This is because higher
uptake rates will result in higher rewards for screening healthier people, and then policies
that screen people earlier (longer diagnosis lead time), thus bring about more gained QALYs.
Lower transition probabilities between health states means patients take more time to
develop diabetes. This results in policy graphs with more nodes and screenings can be


















































































































































































































































































































































































































































































































































opposite happens on the hand when transition probabilities increase. We also see more cost-
effective policies with more QALYs gained as well as longer diagnosis lead times when a
more accurate predictive model (better observation probabilities) is available.
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Chapter 4
Resource Allocation Under Uncertainty for Emergency Situations
(P2)
The Emergency Response Bureau and Special Operations of the Dallas Fire and Rescue
Department (DFRD) encompasses two operational divisions. One of these divisions,
Emergency Response, is responsible for the day-to-day operations involving normal fire
suppression and emergency first responder calls. The Emergency Response Division provides
the residents of Dallas with fire suppression and protection, emergency rescue capabilities,
and emergency medical first responder services. Customer Service is DFRD’s primary goal
for the citizens of Dallas, to be obtained through providing safety, mitigating emergency
situations, and reducing loss of any kind.
An important question for the DFRD is whether resources should be moved around in
the city to cover areas where the resources are currently responding to an incidence. Every
time an incident happens resources in a particular zone of the city will be dispatched and
become unavailable for several hours. If another incident happens in that zone during that
time, resources from other areas of the city will need to respond which will increase response
time. In this chapter I will describe the application of the decision framework to the problem
of finding an optimal resource allocation policy.
4.1. The need for a resource reallocation policy
A Battalion is a combination of several fire stations working together to deal with
situations. They are spread out in the city in a way that each Battalion covers a specific area
of the city. The area that we define as city zone, includes several fire stations all working
together under the same Battalion. Battalions are responsible to respond to incidents
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happening in the city zone under their control. The DFRD battalions, the territory under
their observance and their fire stations are shown in Figure 4.1.
Although each battalion is supposed to respond to the incidents happening in its territory,
there are situations in which on battalion does not have enough resources to respond to a new
incident since all or the majority of the resources of the zone are already dealing with other
incidents. Using the data available from the DFRD, we can analyse if there are situations
which one zone does not have enough resources to respond to incidents happening in it and
asks for extra resources from other zones (battalions) of the city. We visualize some examples
in Figure 4.1.
To be able to see these situations, we have focused only on one zone (battalion) of the
city of Dallas and this is the downtown area to which battalion 1 responds.
The small purple dots that form lines from other zones to zone 1 are emergency vehicle
locations during the dispatch process from their original stations in other zones to incident
locations in zone 1 (light pink area in downtown). We can notice that there are many
instances of requesting resources from other battalions for incidents happening in zone 1
(Table 4.1).
From Zone (Battalion) Total Per Week Average Response Time
3 13675 131 6.1
6 2663 25 6.76
9 1930 19 6.85
8 1682 16 6.83
5 792 8 6.58
4 285 3 9.11
7 181 2 7.4
2 103 1 6.95
Table 4.1: Dispatches from other zones to zone 1 from 2015 to 2017
These happen at the moment the incidents happen and the time it takes for the resources
to get to the incidents’ locations from other zones are significantly larger than usual (Table
4.1).
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Figure 4.1: AVL of vehicles from other zones responding to incidents in zone 1
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The average response times shown in Table 4.1 are way above the limit DFRD is trying
to keep its response times under (6 minutes) and in emergency situation not just minutes
but even seconds count since the lives of people are in danger. With a proper reallocation
policy that is implemented in advance, these response times can be cut shorter.
4.2. The Partially Observable Markov Decision Process Formulation
In order to apply the framework proposed in chapter 2, we need to formulate the problem
as a POMDP problem. To do so we focus on one city zone in order to define our state space.
We try to capture the availability of the resources in that zone in the near future; i.e. the
states of our model are trying to describe the status of a particular zone in the near future.
This near future depends on how long in advance we want to be aware of the future and also
the risk associated with the problem. In this research we define near future as 15 minutes
from the current time. By defining what would be the status of a zone in the near future as
the state of the model, we add unobservability to the model and since only in the future we
will for sure know the answer to this question, the state space is always unobservable to us.
The two main variables that affect the state of the system are: the availability of
the resources in the near future, and the road condition in the near future. The model
has therefore a two-dimensional state space where one dimension is the remaining system
capacity, and the other is the road condition. We have no control over the road conditions
but the system capacity is fully under our control. Below, we define and introduce all the
components of the POMDP model.
4.2.1. State Space
The state sapce of the POMDP has two dimensions. One dimension is the remaining
capacity of the system (the proportion of the resources available and ready for dispatch).
We categorize this dimension into 3 categories called, low capacity, medium capacity, and
high capacity; which translates into what proportion of the resources is available or would be
available within a short period of time from now (near future). Thus Scap = {low,med, high}.
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The other dimension of the state space represents the road condition. Here we only assume
traffic, but other conditions such as weather conditions can be used as well. We categorize this
state into normal hours or no major traffic on the road, and rush hour or major traffic on the
road; the latter corresponds to higher travel times. Thus Sroad = {no− traffic, traffic}.
Considering these two dimensions for the state space, the state space will have a total of





No traffic sN,H sN,M sN,L
Traffic sT,H sT,M sT,L





Figure 4.2: POMDP model, state space and observation space with arcs
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4.2.2. Action Space
There are two available actions for each state of the system: one is to (1) Ask for extra
resources from other zones that can provide the requested resource and the other one (2) is
not to ask for any extra resources (the second action is simply not doing anything until the
next epoch). Thus the action set would be A = {aask, anothing}.
4.2.3. Observations
We define one observation for each state of the system. These observations would be
produced using a predictive model from a combination of signals that come directly from
the system. Each observation points to one state of the system. The set of observation then
would be Ω = {oN,H , oN,M , oN,L, oT,H , oT,M , oT,L}.
4.2.4. Cost Structure
The costs in this POMDP model associated with each action and state are in the form of
travel times. Thus c(s, a) is the average travel time of emergency vehicles given the system
is in state s and action a is taken.
4.3. Parameter Estimation
In this section we use the same methods previously introduced in chapter 2 to estimate
all the parameters associated with the POMDP model.
4.3.1. Data Description
The data used in this application of the research is provided by the Dallas Fire and Rescue
Department. The data mainly consists of the Automated Vehicle Locations (AVL) of the
emergency vehicles used by DFRD, information on incidents responded to by the DFRD and
the status of the vehicles used. Below is a brief description of each of these data components.
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AVL data: The AVL data consists of the locations of the vehicles dispatched to the
incidents recorded at various points in time during the response time. The AVL data
contains:
• Incident number: a unique ID assigned to each incident. This column indicates what
incident the vehicle was dispatched for.
• Radio name: a unique ID that indicates the type of the vehicle dispatched.
• Date and Time: the exact date and time of the recorded vehicle location.
• Latitude and Longitude: the exact coordinates of the vehicle location at the recorded
moment.
• Heading: a number between 0 and 360 indicating the heading of the vehicle at the
moment.
• Speed: the speed of the vehicle in miles per hour at the recorded moment.
Status data: The status data contains information about the exact date and time of the
changes in the status of the vehicles dispatched to the incidents. The status data contains:
• Incident number: a unique ID assigned to each incident. This column indicates what
incident the vehicle was dispatched for.
• Radio name: a unique ID that indicates the type of the vehicle dispatched.
• Assigned: date and time of the moment the vehicle was assigned.
• Enroute: date and time of the moment the vehicle started moving.
• Arrived: date and time the vehicle arrived to the incident location.
• Cleared: date and time the vehicle cleared the situation.
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Incidents data: The status data contains information about the exact location, date and
time of the incidents occurred. The incidents data contains:
• Incident number: a unique ID assigned to each incident.
• Response date and time: the date and time of the occurrence of the incident.
• Address: the address where the incident happened.
• Postal code.
• Longitude and Latitude: the coordinates of the location of the incident.
Table 4.3 provides some basic information on the data provided by the DFRD.
Distribution of the incident length defined as the time between assigning a vehicle and
clearing the situation is depicted in Figure 4.3. Although the majority of the incidents get
cleared in less than an hour, there are still significant number of incidents that take longer
than that. These incidents will keep the system busy for longer than normal incidents and
thus bring down the remaining capacity of the system.
The data can also provide us with the distribution of the remaining capacity of the system.
Figure 4.4 shows this distribution for zone 1 of the city. Although the majority of the time,
the system has high remaining capacity, still there are quite significant number of times where
the remaining capacity of the system hits lower than usual. As we can see the distribution
has a long tail on the left side indicating that the remaining capacity can get very low at
some times.
4.3.2. Estimating Transition Probabilities
To estimate the transition probabilities, we need to use data to estimate the system state
at each point in time. since the state space is 2 dimensional, we need to first estimate each
dimension and then combine the two dimensions to get the actual state of the system.
For the road condition dimension of the state space, we use the rush hours from Dallas city.






























































































































































































































































































































































































































































































































































































Figure 4.3: Incident length distribution for zone 1 (minutes)
For the remaining system capacity we use the number of emergency vehicles that are
available at the moment.
Given the above information we can calculate the transition probabilities. Tables 4.4 and
4.5 represent the transition probabilities for action aask and action anothing respectively.
4.3.3. Estimating observation probabilities
Same as the previous application, we develop a predictive model to produce both
observations and observation probabilities. The outcome of the predictive model would
be one of the observation defined in the previous section which belongs to the set Ω =
{oN,H , oN,M , oN,L, oT,H , oT,M , oT,L}.
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Figure 4.4: Distribution of the remaining capacity of the system for zone 1
The prediction is the state of the system and the independent variables are as follow:
• Current remaining capacity of the system:
• Current road condition
• Day of the week
• Time of the day
• Current month
• Number of incidents happened in the last epoch
Given the above features and target variable we then use Multinomial Logistic Regression




sN,H sN,M sN,L sT,H sT,M sT,L
Starting state
sN,H 0.99 0 0 0.01 0 0
sN,M 0.99 0 0 0.01 0 0
sN,L 0.99 0 0 0.01 0 0
sT,H 0.03 0 0 0.97 0 0
sT,M 0.02 0 0 0.98 0 0
sT,L 0.006 0 0 0.994 0 0
Table 4.4: Transition probabilities for action aask
Transition Probabilities (a2)
Ending state
sN,H sN,M sN,L sT,H sT,M sT,L
Starting state
sN,H 0.92 0.065 0.004 0.01 0.001 0.00
sN,M 0.093 0.83 0.063 0.008 0.005 0.001
sN,L 0.043 0.089 0.85 0.005 0.006 0.007
sT,H 0.027 0.004 0.00 0.87 0.106 0.007
sT,M 0.02 0.015 0.002 0.088 0.80 0.075
sT,L 0.009 0.011 0.016 0.035 0.099 0.83
Table 4.5: Transition probabilities for action anothing
then predicts the state of the system given the features defined above and the prediction is
used as an observation for the POMDP.
For the observation probabilities, according to what we defined before, we will use the
prediction performance in the form of a confusion matrix. This is shown in Table 4.6.
4.3.4. Costs
Since the most important performance metric for the DFRD is the response times, we
focus on defining our POMDP cost structure based on the same metric. We are trying to
reduce the response times as much as possible using the proposed policy.
The basic costs element would be the average response time of the emergency vehicles.
Before that we need to mention that there seems to be a relationship between the response







oN,H oN,M oN,L oT,H oT,M oT,L
State (Actual)
sN,H 0.9 0.065 0.004 0.019 0.0015 0.0005
sN,M 0.1 0.82 0.063 0.008 0.006 0.003
sN,L 0.05 0.089 0.84 0.004 0.01 0.007
sT,H 0.03 0.004 0.00 0.86 0.096 0.009
sT,M 0.02 0.016 0.002 0.087 0.80 0.075
sT,L 0.01 0.02 0.016 0.035 0.099 0.82
Table 4.6: Observation probabilities (confusion matrix) from the predictive model
Figure 4.5: Average response time for each remaining capacity level of the system
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Figure 4.5 shows that average response time increases as the remaining capacity of the
system decreases. We descretize the remaining capacity of the system into 3 levels. Figure
4.5 shows that there are also 3 levels of response time. Table 4.7 shows the costs given the
state of the system and the action taken.
Costs
State
sN,H sN,M sN,L sT,H sT,M sT,L
Action
aask 4.2 6.8 8.7 9.7 10.2 12.4
anothing 4.2 5.8 6.7 6.9 8.6 10.1
Table 4.7: Action and state dependent costs of the POMDP model (in minutes)
Since action anothing indicates asking for help immediately when an incident happens
and there are no resources available, the three elements of the matrix including
c(anothing, sN,H), c(anothing, sN,M), c(anothing, sN,L) are average response under different re-
maining capacity levels obtained from data. The other three elements of the matrix relating
to action 2 including c(anothing, sT,H), c(anothing, sT,M), c(anothing, sT,L) are obtained the same
but they are for when the system is experiencing traffic.
For c(aask, sN,H), there are no extra costs compared to the c(anothing, sN,H) case, since
asking for help not only does not affect the current remaining capacity of the zone 1, but
also it does not take too much capacity from the zone asked from (literally just a few engines
are asked and this does not change the capacity level of the other zone and also does not
really change the current capacity of the zone 1 and thus really does not affect the response
time). For c(aask, sN,M), we have the cost of c(anothing, sN,M) as well as the cost of the
other zone changing from sN,H to sN,M (which is the difference between c(anothing, sN,M) and
c(anothing, sN,H)). For c(aask, sN,L) we have the cost of c(anothing, sN,L) as well as the cost of the
other zone changing from sN,H to sN,L (which is the difference between c(anothing, sN,L) and
c(anothing, sN,H)). For the other three costs, i.e. c(aask, sT,H), c(aask, sT,M), and c(aask, sT,L),
the logic is the same but with one difference, and the difference is that, this time the other
zone will have some costs, even for the c(aask, sT,H) case and the reason is that we now have
traffic and it is not a good idea to lose capacity. Note that the main logic behind these costs
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12 a1: ask for help
a2: do not ask for help
Figure 4.6: costs of POMDP model in minutes for each action and state
is that: by asking for help nothing happens immediately to zone 1 (since it takes time for
vehicles to get there) but we have some costs inferred from the other zone immediately (since
they dispatch the vehicles as soon as we ask and thus they immediately lose capacity).
Figure 4.6 also shows the costs in a single plot.
4.4. Optimal Reallocation Policy
Using the parameters estimated in previous section and the model developed before, we
can now solve the formulated POMDP using the finite grid method over a horizon of 90
days. The optimal policy that POMDP returns is shown in Table 4.8 as follows.
4.5. Policy Evaluation using Simulation




Action oN,H oN,M oN,L oT,H oT,M oT,L
Value function segments
(Policy Nodes)
1 aask 10 4 1 1 1 1
2 anothing 10 9 3 1 1 1
3 anothing 10 8 9 1 1 1
4 anothing 10 9 7 1 1 2
5 anothing 10 8 9 1 1 2
6 anothing 10 8 7 1 2 2
7 anothing 10 8 9 1 3 5
8 anothing 10 8 9 5 3 9
9 anothing 10 8 9 3 3 3
10 anothing 10 8 9 2 3 5
Table 4.8: Optimal reallocation policy produced by POMDP
zone of city during 90 days, with limited number of resources and compare the proposed
policy to when the policy is to ask immediately for help if there are no resources available
and an incident has happened.
To better simulate the system we estimate the parameters of the simulation including the
distributions of response time and incidents’ inter-arrival times.
4.5.1. Simulation parameter estimation
In this section we estimate the following set of parameters using the available data.
• Incidents inter-arrival time (distribution)
• Type of incident
• Number of resources to dispatch
• Response time (distribution)
• Clearance time (distribution)
Incidents inter-arrival time distribution estimation: For the incidents inter-arrival
times, we fit multiple distributions including the exponential distribution as this is expected
to be the one that fits the most using the maximum likelihood method. Figure 4.7 shows
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fitted distributions alongside the Q-Q plot for the theoretical quantiles. As it is inferred
from the plot, exponential distribution fits the data the best and also is not rejected by the
tests. The results for the tests are provided in Table 4.9.













































Figure 4.7: The fitted distributions of incidents inter-arrival times
Table 4.9: Distribution fitting analysis for incidents inter-arrival times
Inter-arrival times
Distributions













Kolmogorov-Smirnov statistic 0.057 0.192 0.062 0.053 0.061
Cramer-von Mises statistic 44.56 793.3 32.27 48.46 34.97
Anderson-Darling statistic 369.43 4521.8 295.8 347.79 303.0
Goodness-of-fit
criteria
Akaike’s Information Criterion 531352.1 603937.1 533648.4 533424.6 533642.4
Bayesian Information Criterion 531370.4 603955.5 533657.6 533442.9 533660.8
Type if incidents: For the types of the incidents that happen, we simply use the number
of resources required to handle the incident. We use the frequency of each type of incident as
the probability of that type of incident. These frequencies and their respective probabilities
are given in Table 4.11.
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Table 4.10: Distribution fitting analysis for response times
Response times
Distributions













Kolmogorov-Smirnov statistic 0.144 0.172 3.354615e-01 0.125 0.157
Cramer-von Mises statistic 213.535 430.68 1.987939e+03 195.86 317.37
Anderson-Darling statistic 1246.5 Infinite 1.013887e+04 1111.83 1931.8
Goodness-of-fit
criteria
Akaike’s Information Criterion 296725.9 328277.4 353039.7 298307.1 309576.9
Bayesian Information Criterion 296744.2 328295.8 353048.9 298325.4 309595.2
The number of resources required to handle each incident type depends the incident type
as this is how we defined the incident type.
Response time distribution estimation: To find the distribution that best fits the
distribution of response times, we fit multiple distributions including the normal, log normal,
gamma, and Weibull distributions using the maximum likelihood method. Figure 4.7 shows
fitted distributions alongside the Q-Q plot for the theoretical quantiles. As it is inferred
from the plot, the log normal distribution fits the data the best and also is not rejected by
the tests. The results for the tests are provided in Table 4.10.
Clearance time: The clearance time which is the time it takes for the resources to handle
the situation, clear it and get back to the stations and eventually get ready for the next
incident depends on the incident type. This is clearly shown in Figure 4.9 where clearance
time is depicted with relation to the incident type. Thus we estimate this from the data for
each incident type and provide the averages for each in Table 4.11.
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Table 4.11: Incident types and their respective probabilities of happening
Incident type Frequency Probability Average clearance time (minutes)
1 45497 0.61 33.56
2 18473 0.24 18.58
3 7643 0.10 13.09
4 1468 0.019 12.36
5 358 0.004 12.12
6 153 0.002 16.9
7 173 0.002 14.14
8 78 0.001 15.16
9 49 0.0006 10.9
10 43 0.00057 34.09
11 36 0.00048 46.7
12 18 0.00024 27.57
13 14 0.00018 34.09
14 42 0.00056 18.12
15 39 0.00052 20.01
16 24 0.00032 19.7
17 11 0.00014 14.1721
18 5 0.00006 17.52
19 6 0.00008 17.93
20 2 0.000026 33.77
21 2 0.000026 61.9
22 1 0.000013 59.5
24 1 0.000013 65.3
26 1 0.000013 104.42
28 1 0.000013 68.07
29 1 0.000013 74.86
30 1 0.000013 76.56
31 1 0.000013 97.548
39 3 0.00004 108.48
40 1 0.000013 112.32
41 1 0.000013 94.9
44 1 0.000013 101.17
53 1 0.000013 163.45
56 1 0.000013 157.23
65 1 0.000013 232.32
66















































Figure 4.8: The fitted distributions of response times
Figure 4.9: The average clearance time for each type of incident
67
Based on Figure 4.9 the average clearance time increases as the type of incident increases
(more severe incidents).
4.5.2. Evaluation using simulation
Using the parameters estimated and calculated in the previous section, we simulate one
zone of the city with a limited number of resources (similar to zone 1 of the city of Dallas,
we only have 24 emergency vehicles available). We compare two different scenarios:
• Scenario 1: The DFRD asks for extra resources from other zones only when an incident
happens and not enough resources are available to respond
• Scenario 2: The DFRD follows the proposed POMDP policy demonstrated in Table
4.8 and asks for extra resources whenever the policy implies.
We then run the simulation for 90 days and 30 replications and compare the two scenarios
in various metric presented in Table 4.12.
According to Table 4.12 by implementing the proposed POMDP policy we can improve
the average response time by almost 48 seconds (by 13%) which is a significant improvement
in emergency situations. We can also decrease the number of times not enough resources
are available to respond to an incident by almost 80 percent. This means that our system
will have less chances of having not enough resources available to respond to an incoming
incident. We also decrease the number of resources requested when not enough resources are
available by around 66 percent. This means even if we are asking for extra resources from
other zones, this request comes in very small amounts. POMDP policy tends to keep the
system at full capacity while without such a policy the average remaining capacity of the
system is around 67 percent. Implementing the proposed policy will result in spending more
time in state 1 and 4 compared to the time where no such policy is implemented in which


































































































































































































































































































































































































The framework proposed in this work focuses on using historical data to develop a
predictive model that provides fewer but more accurate observations from a system modeled
as a POMDP. The focus of the framework is first, to reduce the dimensionality of the
observation space of the POMDP by selecting only a collection of signals that provides a
single observations, and second, to provide more accurate observations by aggregating the
selected signals using a predictive model that predicts the state of the system. Using the
framework, we reduce the size of the problem by a large (exponential) factor while sacrificing
only little in terms of the quality of the resulting POMDP policy. We also avoid the effort
required to estimate all the observation probabilities which can be a difficult task when not
enough data is available. This task is easily handled by the predictive model and from the
data available and these probabilities are then provided more accurately.
The effectiveness of the proposed framework depends on the data available, but this is
generally true for using POMDPs since parameters need to be estimated. The framework
provides all the advantages of predictive modeling including methods for feature selection,
dealing with missing data and data quality issues. When using this framework, the predictive
model is trained supervised, i.e., the training data needs to be annotated with class
information. This means that at some point in time, information on the actual states of
the system must have been recorded along with the signal values. Otherwise, no predictive
model can be developed based on the available data.
The framework can also be used by aggregating groups of signals into several types of
observations. So far, we have only considered a single signal aggregated from a selected set
of signals. This selection is only based on the accuracy of signals from the system. But in the
future, the framework can expand in a way that provides various signals each a combination
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of a different set of signals from the system. The sets can include signals that are more
related to each other or are from the same part of the system or their nature is closer to each
other. The relationship between signals can also be learned from data using unsupervised
learning technique after the signal selection step to group signals into sets.
The proposed framework is then utilized in two different applications.
5.1. Optimal Individualized Diabetes Screening
Diabetes, a prevalent chronic disease affecting over 30 million American adults, is
associated with multiple comorbidities and is the seventh-leading cause of death in the United
States. The disease, associated with hundreds of billions of dollars in direct and indirect costs
(ADA 2018), progresses with a lengthy asymptomatic period of 9 to 12 years, on average (Lu
et al. 2010). Thus, it is critical to screen patients who have undiagnosed diabetes or those
who are at an elevated risk of developing diabetes as this can result in substantial savings,
since appropriate interventions can be put in place to prevent progression to diabetes and
development of diabetes complications. Existing guidelines such as those from ADA (ADA
2019) are generic and cost-prohibitive if implemented on the entire population, since (i) only
9.4 percent of the population is at risk of developing diabetes (CDC 2017), and (ii) the gold
standard test (using A1c) for screening is very expensive (Chatterjee et al. 2013). There
does not exist, to the best of our knowledge, a personalized screening strategy for detecting
patients with diabetes or prediabetes. This is exactly what this paper attempts to do.
In this study, we propose a targeted screening policy (equivalently, screening strategy) that
uses all available information on individual patients to identify whom to screen (that is, which
patients should receive the gold-standard test) and when to screen them; the policy is also
age-specific. Our proposed policy relies on multiple methods and is based on actual patient
data (available in the form of EHRs), making it practically implementable. In particular,
POMDP is used for determining optimal decisions at each time period (a year) while HMM
and PRM are used to generate the transition and observation probabilities, respectively,
for POMDP. Thus, a key contribution of this work is the holistic integration of the three
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methods to answer a practical healthcare decision-making problem of this magnitude.
We develop and validate our model on a detailed and proprietary dataset – of over
12,000 patients over an 18-month period – from a large safety-net hospital and demonstrate,
using a detailed simulation analysis, that our proposed screening policy can improve patient
outcomes by 106 percent - at only 65 percent of the cost – compared with existing guidelines.
Our detailed sensitivity analyses show no significant or unjustifiable change in the results of
the simulation due to changes in the model parameters.
The integration of data analytics with optimization methods has become increasingly
critical to solve important problems in healthcare and beyond. In this study, we have
demonstrated how existing methods can be combined with POMDP to produce an optimal
screening policy that incorporates cohort-specific characteristics as well as individualized
medical information.
Our study has several limitations. From a methodological standpoint, first, the use of
POMDP approach relies on a potentially strong assumption that the Markov property holds,
at least approximately. However, our assumption is consistent with previous work, where
experts have argued that Markov models are useful approximations for disease progression
models. Second, our state space is primarily based on a single measure (A1c), resulting
in a simplistic single dimensional state space. However, our review of the literature and
conversations with our clinical co-author reveal that A1c is the most commonly used
test in clinical practice to screen and diagnose patients for diabetes. While inclusion of
additional covariates may enrich the model, it also increases the model complexity and the
computational effort required to solve such a model. Third, we only consider two actions
– screen or do not screen (the latter being essentially an absence of action). However,
expanding the action space will require the estimation of all associated transition parameters.
Therefore, smaller state and action spaces are preferable from a practical standpoint. Fourth,
estimation of the disease progression rates relies on the available screening results from
the EHR data and is, thus, applicable only to screened patients with visits in the health
system studied. We estimate the transition rates of unscreened patients by using a factor
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representing treatment effectiveness. This is a simplistic approach that requires more
research. Finally, our analysis is limited to patients at a single hospital who may not
share the same characteristics with patients in other hospitals. However, we believe our
methodological approach is generalizable and can be applied to patients in other settings,
with modifications.
5.2. Resource Allocation Under Uncertainty for Emergency Vehicles
An important question for the DFRD is whether resources should be moved around in
the city to cover areas where the resources are currently responding to an incidence. Every
time an incident happens resources in a particular zone of the city will be dispatched and
become unavailable for several hours. If another incident happens in that zone during that
time, resources from other areas of the city will need to respond which will increase response
time. To mitigate such situations, we can temporarily reallocate resources.
We apply framework proposed in chapter 2, and formulate the problem as a POMDP
problem. We focus on one city zone in order to define our state space. We try to capture the
availability of the resources in that zone in the near future; i.e. the states of our model are
trying to describe the status of a particular zone in the near future. This near future depends
on how long in advance we want to be aware of the future and also the risk associated with
the problem. By defining what would be the status of a zone in the near future as the state
of the model, we add unobservability to the model and since only in the future we will for
sure know the answer to this question, the state space is always unobservable to us.
By implementing the proposed POMDP policy, and through simulation, we demonstrate
that we can improve the average response time by almost 48 seconds which is a significant
improvement in emergency situations. We can also decrease the number of times not enough
resources are available to respond to an incident by almost 80 percent. This means that
our system will have less chances of having not enough resources available to respond to an
incoming incident. We also decrease the number of resources requested when not enough
resources are available by around 66 percent. This means even if we are asking for extra
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resources from other zones, this request comes in very small amounts. POMDP policy tends
to keep the system at full capacity while without such a policy the average remaining capacity
of the system is around 67 percent. Implementing the proposed policy will result in spending
more time in state 1 and 4 compared to the time where no such policy is implemented in




In this section we provide details on the simulation conducted for the fist application in
this work. The simulation consists of a hypothetical cohort of 50,000 patients starting from
age 30 to age 79, with characteristics described in Table 3.1. We simulate seven different
scenarios representing different screening policies, including our proposed one. The only
difference between these scenarios is the screening policy implemented. The six scenarios
that use the existing or hypothetical guidelines are similar to each other thus only one of
them will be explained here along with the proposed policy. All scenarios are compared
to the base scenario. The base scenario is when there is not a specific screening policy
(commonly called opportunistic screening). This means that we screen patients if they show
up and have symptoms or if they request so, but we never prescribe screening for them or
ask them to show up later for a screening test.
The simulation is an aging loop where patients enter with the age of 30 and leave either
when they die or reach the age of 79 as demonstrated in Figure A.1. We explain here each
part of the simulation loop in details.
A.1. Patient Instantiation
We instantiate each patient using the prevalence rate of each of the stages of the disease
in the cohort described in Table 3.1. These prevalence rate are taken from Table 3.1. We
also assign diabetes complications to the patients that already have Diabetes using the
prevalence rates from Chen et al. (2001), Howard et al. (2010), and Kahn et al. (2010).
These complications along with the diabetes progression Markov models are demonstrated
in Figure 3.6. The prevalence rates for each of the states of the models in Figure 3.6 are
provided in Table A.1.
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Figure A.1: Simulation loop for the base scenario
A.2. Updating Health Status
At the beginning of each iteration, patients’ health status gets updated using the
progression rates obtained via HMM and from Chen et al. (2001), Howard et al. (2010),
and Kahn et al. (2010) according to the Markov models demonstrated in Figure 3.6. The
progression rates for each transition is provided in Table A.2.
A.3. Calculating Patient’s Utility
At each iteration, patient’s utility of life is calculated using the EQ-5D index from
Ackermann et al. (2009), Bahia et al. (2017), and P. Zhang et al. (2012). These utilities
are provided in Table A.3. The worst utility is assumed to be the utility of the patient with
multiple chronic conditions and complications.
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NDR NPDR PDR ME B
0.5 0.2 0.05 0.25 0
Nephropathy
NNP MA PR ESRD CVD




Table A.2: Progression rates for transitions in Diabetes and its complications
Disease Transitions
Diabetes
H to P P to H P to D
0.048 0.0328 0.0348
Retinopathy
NDR to NPDR NPDR to PDR NPDR to ME PDR to B ME to B
0.073 0.0103 0.1928 0.0148 0.033
Nephropathy
NNP to MA MA to PR PR to ESRD ESRD to CVD CVD to DE
0.0267 0.1572 0.0042 0.5 0.2
Neuropathy
NNR to SNR SNR to LEA LEA to DE
0.0144 0.028 0.02
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Figure A.2: Diabetes and its complications Markov progression models
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Table A.3: Life utilities for different health conditions









A.4. Check for Diagnosis
For Diabetes and its complications there is usually a time to diagnosis from the onset
of the disease. For Diabetes it is on average 10 years and for its complications it is on
average 3 years (Lu et al. 2010). This means that given there is no screening policy, the
patients will be diagnosed on average after the given amount of time due to major health
problems they face. Thus at each iterations there is a certain chance based on the patient’s
conditions that the patient gets diagnosed with her condition. This is contingent upon the
patient’s showing up and visiting doctor. There is a certain chance associated with that
called patient’s tendency to visit doctor given their health conditions. These probabilities
include on average 10%, 25% and 55% for when they have almost zero symptoms, medium
risk symptoms and high-risk symptoms respectively. The high-risk symptoms are associated
with later stages of the diseases presented in Figure A.2.
A.5. Patient’s Annual Costs
At each year the total annual costs of the patient including Diabetes costs and
Complications costs are calculated using the figures provided in Chen et al. (2001), Howard
et al. (2010), and Kahn et al. (2010). All these costs are provided in US dollars in Table
A.4. All costs are then discounted by 0.03 each year.
A.6. Leaving the Simulation
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Table A.4: All costs associated with Diabetes and its complications




















At the end of each year, the patient will leave the simulation if she dies by any of the
complications or through the natural progression of Diabetes or by reaching the age of 79.
This means that the patients will stay in simulation for at most 50 years and then leave it.
A.7. Implementing POMDP Policy/Other Guidelines
Almost everything is the same as the base scenario except for the screening policy here.
In the POMDP scenario, we have the same chances for patients show-up at the doctors as
the base scenario. Each time the patient shows up, the policy node at which the patient is,
gets updated according to the observation made by the predictive model. At the show-up
where the policy indicates screening, the screening would take place. For other guidelines it
is the same except that guidelines have a fixed frequency of screening and if that matches
with the time that the patient shows up, the screening will take place. Note that in all
scenarios, no screening would happen if the patient does not show up. The simulation loop
for POMDP scenario is depicted in Figure A.3.
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Following is the manual to the R package ’pomdp’ developed during this research. This
package is a solver for Partially Observable Markov Decision Processes. The package enables
the user to simply define all components of a POMDP model and solve the problem using
several methods. The package also contains functions to analyze and visualize the POMDP
solutions (e.g., the optimal policy)








Description Provides an interface to pomdp-solve, a solver for Partially Observable Markov Deci-
sion Processes (POMDP). The package enables the user to simply define all compo-
nents of a POMDP model and solve the problem using several methods. The package also con-
tains functions to analyze and visualize the POMDP solutions (e.g., the optimal policy).
Depends R (>= 3.5.0)





Copyright pomdp-solve is Copyright (C) Anthony R. Cassandra; LASPack
is Copyright (C) Tomas Skalicky; lp-solve is Copyright (C)
Michel Berkelaar, Kjell Eikland, Peter Notebaert; all other
code is Copyright (C) Hossein Kamalzadeh and Michael Hahsler.
NeedsCompilation yes
Author Hossein Kamalzadeh [aut, cph, cre],
Michael Hahsler [aut, cph],
Anthony R. Cassandra [ctb, cph]
Maintainer Hossein Kamalzadeh <hkamalzadeh@smu.edu>
Repository CRAN
Date/Publication 2019-12-16 09:30:08 UTC
R topics documented:
model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
plot . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
policy_graph . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
83
model
POMDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
reward . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
solution . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
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Index 15
model Extract the User-defined Model Components from a Solved POMDP
Description




x object of class POMDP returned by solve_POMDP.
Value










plot Visualize a POMDP Policy Graph
Description
The function plots the POMDP policy graph in an object of class POMDP. It uses plot in igraph
with appropriate plotting options.
Usage
## S3 method for class 'POMDP'
plot(x, y = NULL, belief = TRUE, legend = TRUE, cols = NULL,...)
Arguments
x object of class POMDP.
y ignored.
belief logical; display belief proportions as a pie chart in each node.
legend logical; display a legend for colors used belief proportions?
cols colors used for the states.
... plotting options passed on to plot.igraph in igraph (see plot.common for
available options).
Details
The policy graph nodes represent segments in the value function. Each segment represents one or
more believe states. The pie chart in each node (if available) represent the average belief proportions
of the belief states belonging to the node/segment.
See Also
solve_POMDP, plot.igraph, igraph_options, plot.common
Examples
data("TigerProblem")









## use a different graph layout (circle and manual)
plot(tiger_solved, layout = layout.circle)
plot(tiger_solved, layout = rbind(c(1,1), c(1,-1), c(0,0), c(-1,-1), c(-1,1)))
## hide edge labels
plot(tiger_solved, edge.label = NA)





## add a plot title
plot(tiger_solved, main = model(tiger_solved)$name)
## plotting using the graph object
## (e.g., using the graph in the layout and to change the edge curvature)
pg <- policy_graph(tiger_solved)
plot(pg,
layout = layout_as_tree(pg, root = 3, mode = "out"),
edge.curved = curve_multiple(pg, .2))
policy_graph Extract the Policy Graph (as an igraph Object)
Description
Convert the policy graph in a POMDP solution object into an igraph object.
Usage
policy_graph(x, belief = TRUE, cols = NULL)
Arguments
x A POMDP object.
belief logical; add belief proportions as a pie chart in each node of the graph.
cols colors used for the states in the belief proportions.
Value
An object of class igraph containing a directed graph.
Author(s)











POMDP Define a POMDP Problem
Description
Defines all the elements of a POMDP problem including the discount rate, the set of states, the
set of actions, the set of observations, the transition probabilities, the observation probabilities, and
rewards.
Usage
POMDP(discount, states, actions, observations, transition_prob,
observation_prob, reward, start = "uniform", max = TRUE, name = NA)
R_(action, start.state, end.state, observation, value)
O_(action, end.state, observation, probability)
T_(action, start.state, end.state, probability)
Arguments
discount numeric; discount rate between 0 and 1.
states a character vector specifying the names of the states.
actions a character vector specifying the names of the available actions.
observations a character vector specifying the names of the observations.
transition_prob
Specifies the transition probabilities between states. Options are:
• a data frame with 4 columns, where the columns specify action, start-state,
end-state and the probability respectively. The first 3 columns could be
either character (the name of the action or state) or integer indices.
• a named list of m (number of actions) matrices. Each matrix is square of
size n × n, where n is the number of states. The name of each matrix the
action it applies to. Instead of a matrix, also the strings "identity" or




Specifies the probability that a state produces an observation. Options are:
• a data frame with 4 columns, where the columns specify action, end-state,
observation and the probability, respectively. The first 3 columns could be
either character (the name of the action, state, or observation), integer in-
dices, or they can be "*" to indicate that the observation probability applies
to all actions or states. Use rbind() with helper function O_() to create
this data frame.
• a named list of m matrices, where m is the number of actions. Each matrix
is of size n × o, where n is the number of states and o is the number of
observations. The name of each matrix is the action it applies to. Instead of
a matrix, also the strings "identity" or "uniform" can be specified.
reward Specifies the rewards dependent on action, states and observations. Options are:
• a data frame with 5 columns, where the columns specify action, start.state,
end.state, observation and the reward, respectively. The first 4 columns
could be either character (names of the action, states, or observation), inte-
ger indices, or they can be "*" to indicate that the reward applies to all tran-
sitions. Use rbind() with helper function R_() to create this data frame.
• a named list of m lists, where m is the number of actions (names should
be the actions). Each list contains n named matrices where each matrix is
of size n × o, in which n is the number of states and o is the number of
observations. Names of these matrices should be the name of states.
start Specifies the initial probabilities for each state (i.e., the initial belief state) used
to find the initial node in the policy graph and to calculate the total expected
reward. The default initial belief state is a uniform distribution over all states.
No initial belief state can be used by setting start = NULL. Options to specift
start are:
• a probability distribution over the n states. That is, a vector of n probabili-
ties, that add up to 1.
• the string "uniform" for a uniform distribution over all states.
• an integer in the range 1 to n to specify a single starting state. or
• a string specifying the name of a single starting state.
• a vector of strings, specifying a subset of states with a uniform start distri-
bution. If the first element of the vector is "-", then the following subset of
states is excluded from the set of start states.
max logical; is this a maximization problem (maximize reward) or a minimization
(minimize cost specified in reward)?
name a string to identify the POMDP problem.
action, start.state, end.state, observation, probability, value
Values used in the helper functions O_(), R_(), and T_() to create an entry for
observation_prob, reward, or transistion_prob above, respectively.
Details
POMDP problems can be solved using solve_POMDP. Details about the available specifications can




The function returns an object of class POMDP which is list with an element called model contain-
ing a list with the model specification. solve_POMDP reads the object and adds a list element called
solution.
Author(s)
Hossein Kamalzadeh, Michael Hahsler
References





## The Tiger Problem
TigerProblem <- POMDP(
name = "Tiger Problem",
discount = 0.75,
states = c("tiger-left" , "tiger-right"),
actions = c("listen", "open-left", "open-right"),











# the rew helper expects: action, start.state, end.state, observation, value
reward = rbind(
R_("listen", "*", "*", "*", -1 ),
R_("open-left", "tiger-left", "*", "*", -100),
R_("open-left", "tiger-right", "*", "*", 10 ),
R_("open-right", "tiger-left", "*", "*", 10 ),







reward Calculate the Reward for a POMDP Solution
Description
This function calculates the expexted total reward for a POMDP solution given a starting belief
state.
Usage
reward(x, start = "uniform")
Arguments
x a POMDP solution (object of class POMDP).
start specification of the starting belief state (see argument start in POMDP for details).
Details
The value is calculated using the value function stored in the POMDP solution.
Value
A list with the components
total_expected_reward
the total expected reward starting with the initial policy graph node representing
the starting belief state.
initial_pg_node
the policy graph node that represents the starting belief state.’
start_belief_state









tiger_solved <- solve_POMDP(model = TigerProblem)
# if no start is specified, a uniform belief is used.
reward(tiger_solved)
# we have additional information that makes us belief that the tiger
# is more likely to the left.
reward(tiger_solved, start = c(0.85, 0.15))
# we start with strong evidence that the tiger is to the left.
reward(tiger_solved, start = "tiger-left")
# Note that in this case, the total discounted expected reward is greater
# than 10 since the tiger problem resets and another game staring with
# a uniform belief is played which produces addional reward.
solution Extract the Solution of a POMDP
Description
The function extracts the solution of a POMDP as an object of class POMDP_solution which is a




x object of class POMDP returned by solve_POMDP.
Value










solver_output Display the Output of the POMDP Solver
Description
Displays the output generated by the solver ’pomdp-solve’. This includes used parameters, and





x object of class POMDP returned by solve_POMDP.
Value





sol <- solve_POMDP(model = TigerProblem)
## solver output
solver_output(sol)
solve_POMDP Solve a POMDP Problem
Description
This function utilizes the ’pomdp-solve’ program (written in C) to use different solution methods [2]
to solve problems that are formulated as partially observable Markov decision processes (POMDPs)
[1]. The result is a (close to) optimal policy.
Usage





model a POMDP problem specification created with POMDP. Alternatively, a POMDP
file or the URL for a POMDP file can be specified.
method string; one of the following solution methods: "grid", "enum", "twopass",
"witness", or "incprune". Details can be found in [1].
horizon an integer with the number of iterations for finite horizon problems. If set to
NULL, the algorithm continues running iterations till it converges to the infinite
horizon solution.
parameter a list with parameters passed on to the pomdp-solve program.
verbose logical, if set to TRUE, the function provides the output of the pomdp solver in
the R console.
Details
solve_POMDP_parameter() displays available solver parameter options.
Note: The parser for POMDP files is experimental. Please report problems here: https://github.
com/farzad/pomdp/issues.
Value
The solver returns an object of class POMDP which is a list with the model specifications (model),
the solution (solution), and the solver output (solver_output). The elements can be extracted
with the functions model, solution, and solver_output.
Author(s)
Hossein Kamalzadeh, Michael Hahsler
References
[1] For further details on how the POMDP solver utilized in this R package works check the fol-
lowing website: http://www.pomdp.org
[2] Cassandra, A. Rocco, Exact and approximate algorithms for partially observable Markov deci-




tiger_solved <- solve_POMDP(model = TigerProblem, parameter = list(fg_points = 10))
tiger_solved
## look at the model
model(tiger_solved)




## look at solver output
solver_output(tiger_solved)
## plot the policy graph
plot(tiger_solved)
## display available solver options which can be passed on to the solver as parameter.
solve_POMDP_parameter()




TigerProblem Tiger Problem POMDP Specification
Description




A list with the elements: discount, states, actions, observations, start, transition_prob, observa-
tion_prob, reward, name.
Details
The Tiger Problem is defined as follows [1]. A tiger is put with equal probability behind one of
two doors, while treasure is put behind the other one. You are standing in front of the two closed
doors and need to decide which one to open. If you open the door with the tiger, you will get hurt
by the tiger (negative reward), but if you open the door with the treasure, you receive a positive
reward. Instead of opening a door right away, you also have the option to wait and listen for tiger
noises. But listening is neither free nor entirely accurate. You might hear the tiger behind the left
door while it is actually behind the right door and vice versa.
The states of the system are tiger behind the left door (tiger-left) and tiger behind the right door
(tiger-right).
Available actions are: open the left door (open-left), open the right door (open-right) or to listen
(listen).
Rewards associated with these actions depend on the resulting state: +10 for opening the correct




As a result of listening, there are two observations: either you hear the tiger on the right (tiger-right),
or you hear it on the left (tiger-left).
The transition probability matrix for the action listening is identity, i.e., the position of the tiger
does not change. Opening either door means that the game restarts by placing the tiger uniformly
behind one of the doors.
References
[1] Anthony R. Cassandra, Leslie P Kaelbling, and Michael L. Littman (1994). Acting Optimally
in Partially Observable Stochastic Domains. In Proceedings of the Twelfth National Conference on









write_POMDP Write a POMDP Model to a File in POMDP Format
Description




model an object of class POMDP_model.
file a file name.
Author(s)
Hossein Kamalzadeh, Michael Hahsler
References
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